Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Alzheimer Disease | 528 | 2024 | 905 | 48.540 |
Why?
|
Oxidative Stress | 200 | 2020 | 938 | 14.980 |
Why?
|
Brain | 191 | 2024 | 1346 | 11.960 |
Why?
|
tau Proteins | 106 | 2024 | 167 | 9.460 |
Why?
|
Neurodegenerative Diseases | 47 | 2024 | 131 | 6.930 |
Why?
|
Neurons | 151 | 2021 | 1175 | 6.740 |
Why?
|
Mitochondria | 71 | 2023 | 487 | 6.300 |
Why?
|
Neurofibrillary Tangles | 85 | 2022 | 113 | 5.690 |
Why?
|
Humans | 697 | 2024 | 37093 | 5.670 |
Why?
|
Aging | 53 | 2021 | 664 | 4.980 |
Why?
|
Animals | 323 | 2024 | 15081 | 3.990 |
Why?
|
Dementia | 17 | 2024 | 131 | 3.860 |
Why?
|
Parkinson Disease | 36 | 2019 | 178 | 3.620 |
Why?
|
Oxidation-Reduction | 66 | 2020 | 431 | 3.450 |
Why?
|
Antioxidants | 43 | 2020 | 416 | 3.400 |
Why?
|
Iron | 42 | 2024 | 225 | 3.370 |
Why?
|
Hippocampus | 79 | 2024 | 561 | 3.360 |
Why?
|
Amyloid | 27 | 2023 | 54 | 3.220 |
Why?
|
Amyloid beta-Protein Precursor | 48 | 2019 | 95 | 3.100 |
Why?
|
Peptide Fragments | 34 | 2018 | 308 | 2.820 |
Why?
|
Immunohistochemistry | 112 | 2021 | 893 | 2.510 |
Why?
|
Aged | 186 | 2024 | 6741 | 2.430 |
Why?
|
Nervous System Diseases | 9 | 2022 | 71 | 2.350 |
Why?
|
Evolution, Molecular | 14 | 2021 | 268 | 2.350 |
Why?
|
RNA | 15 | 2017 | 241 | 2.240 |
Why?
|
Neuroprotective Agents | 20 | 2020 | 245 | 2.190 |
Why?
|
Aldehydes | 26 | 2013 | 69 | 2.140 |
Why?
|
Aged, 80 and over | 123 | 2020 | 2379 | 2.130 |
Why?
|
Reactive Oxygen Species | 39 | 2020 | 461 | 2.040 |
Why?
|
Selection, Genetic | 5 | 2021 | 54 | 2.030 |
Why?
|
Nerve Degeneration | 25 | 2018 | 107 | 2.000 |
Why?
|
Genome, Human | 10 | 2021 | 135 | 1.990 |
Why?
|
Metals | 18 | 2020 | 98 | 1.860 |
Why?
|
Genome | 6 | 2021 | 125 | 1.830 |
Why?
|
Tauopathies | 7 | 2022 | 20 | 1.810 |
Why?
|
Neurofilament Proteins | 15 | 2013 | 29 | 1.770 |
Why?
|
Disease Models, Animal | 45 | 2024 | 1371 | 1.690 |
Why?
|
Lipid Peroxidation | 22 | 2013 | 140 | 1.690 |
Why?
|
Protein Processing, Post-Translational | 12 | 2018 | 173 | 1.640 |
Why?
|
Genetic Variation | 14 | 2022 | 387 | 1.640 |
Why?
|
Cerebral Cortex | 39 | 2023 | 290 | 1.590 |
Why?
|
Guanosine | 17 | 2017 | 27 | 1.590 |
Why?
|
DNA, Mitochondrial | 17 | 2022 | 175 | 1.590 |
Why?
|
Mice, Transgenic | 43 | 2024 | 617 | 1.550 |
Why?
|
Mice | 98 | 2024 | 5913 | 1.490 |
Why?
|
Pan troglodytes | 6 | 2010 | 21 | 1.490 |
Why?
|
Proteins | 12 | 2020 | 369 | 1.470 |
Why?
|
Thermodynamics | 5 | 2018 | 216 | 1.430 |
Why?
|
Biomedical Research | 8 | 2022 | 400 | 1.430 |
Why?
|
Free Radicals | 24 | 2010 | 74 | 1.410 |
Why?
|
Copper | 20 | 2018 | 105 | 1.370 |
Why?
|
Encephalitis | 6 | 2023 | 42 | 1.360 |
Why?
|
Up-Regulation | 16 | 2020 | 513 | 1.360 |
Why?
|
Autophagy | 10 | 2017 | 116 | 1.300 |
Why?
|
Clinical Trials as Topic | 11 | 2023 | 204 | 1.280 |
Why?
|
Nerve Tissue Proteins | 28 | 2015 | 360 | 1.260 |
Why?
|
Gene Dosage | 8 | 2008 | 75 | 1.240 |
Why?
|
Nanoparticles | 8 | 2019 | 318 | 1.230 |
Why?
|
Lemur | 2 | 2021 | 4 | 1.210 |
Why?
|
Hormones | 6 | 2018 | 55 | 1.200 |
Why?
|
Middle Aged | 121 | 2020 | 10129 | 1.190 |
Why?
|
Phenotype | 11 | 2022 | 689 | 1.190 |
Why?
|
Nanotechnology | 3 | 2018 | 153 | 1.190 |
Why?
|
Cell Nucleus | 11 | 2021 | 366 | 1.130 |
Why?
|
Apolipoproteins E | 13 | 2020 | 129 | 1.130 |
Why?
|
Body Height | 2 | 2022 | 53 | 1.130 |
Why?
|
Editorial Policies | 3 | 2018 | 13 | 1.130 |
Why?
|
Phosphorylation | 47 | 2024 | 928 | 1.120 |
Why?
|
Nucleic Acids | 4 | 2017 | 24 | 1.100 |
Why?
|
alpha-Synuclein | 12 | 2023 | 52 | 1.090 |
Why?
|
Telomere | 2 | 2016 | 56 | 1.040 |
Why?
|
Cerebrovascular Disorders | 9 | 2008 | 37 | 1.040 |
Why?
|
Neurites | 11 | 2017 | 39 | 1.010 |
Why?
|
Genetics, Population | 4 | 2021 | 100 | 1.000 |
Why?
|
Genomics | 8 | 2023 | 223 | 0.990 |
Why?
|
Adaptation, Physiological | 6 | 2023 | 109 | 0.990 |
Why?
|
Neurology | 2 | 2018 | 12 | 0.980 |
Why?
|
Phylogeny | 6 | 2021 | 644 | 0.970 |
Why?
|
Primates | 3 | 2011 | 36 | 0.960 |
Why?
|
T-Lymphocytes, Regulatory | 1 | 2024 | 59 | 0.950 |
Why?
|
Cytoskeleton | 19 | 2002 | 110 | 0.940 |
Why?
|
Cognition | 13 | 2023 | 398 | 0.930 |
Why?
|
Male | 119 | 2024 | 20025 | 0.920 |
Why?
|
Brain Chemistry | 23 | 2020 | 140 | 0.920 |
Why?
|
Membrane Proteins | 28 | 2018 | 517 | 0.910 |
Why?
|
Models, Neurological | 9 | 2018 | 128 | 0.910 |
Why?
|
DNA | 11 | 2021 | 574 | 0.900 |
Why?
|
Energy Metabolism | 7 | 2018 | 168 | 0.890 |
Why?
|
Hyperinsulinism | 1 | 2022 | 17 | 0.880 |
Why?
|
Neurofibrils | 16 | 2013 | 23 | 0.870 |
Why?
|
Amyloidosis | 11 | 2023 | 33 | 0.860 |
Why?
|
Entorhinal Cortex | 4 | 2020 | 13 | 0.860 |
Why?
|
Agriculture | 2 | 2022 | 56 | 0.840 |
Why?
|
RNA, Transfer | 3 | 2018 | 28 | 0.840 |
Why?
|
Female | 113 | 2024 | 20969 | 0.840 |
Why?
|
Skeleton | 1 | 2022 | 2 | 0.840 |
Why?
|
Pyramidal Cells | 12 | 2018 | 63 | 0.830 |
Why?
|
Mitochondrial Proteins | 14 | 2018 | 107 | 0.830 |
Why?
|
Multifactorial Inheritance | 2 | 2019 | 19 | 0.830 |
Why?
|
Protein Biosynthesis | 4 | 2018 | 133 | 0.820 |
Why?
|
Health | 1 | 2022 | 30 | 0.820 |
Why?
|
Vaccines | 1 | 2023 | 55 | 0.810 |
Why?
|
Microscopy, Electron | 32 | 2021 | 209 | 0.810 |
Why?
|
Immunoblotting | 37 | 2010 | 176 | 0.810 |
Why?
|
Diabetic Retinopathy | 1 | 2022 | 68 | 0.800 |
Why?
|
Prediabetic State | 1 | 2022 | 53 | 0.800 |
Why?
|
Extinction, Biological | 1 | 2021 | 2 | 0.800 |
Why?
|
DNA Damage | 12 | 2021 | 352 | 0.790 |
Why?
|
Somatotypes | 1 | 2021 | 4 | 0.790 |
Why?
|
Publishing | 2 | 2020 | 24 | 0.790 |
Why?
|
Heme Oxygenase (Decyclizing) | 17 | 2004 | 30 | 0.790 |
Why?
|
Thioctic Acid | 4 | 2009 | 14 | 0.790 |
Why?
|
Anthropology, Physical | 1 | 2021 | 9 | 0.780 |
Why?
|
Genome, Mitochondrial | 1 | 2021 | 12 | 0.780 |
Why?
|
Body Size | 1 | 2021 | 32 | 0.780 |
Why?
|
Down-Regulation | 4 | 2020 | 435 | 0.770 |
Why?
|
Gastropoda | 1 | 2021 | 11 | 0.770 |
Why?
|
MAP Kinase Signaling System | 6 | 2017 | 169 | 0.760 |
Why?
|
Iron Chelating Agents | 6 | 2012 | 21 | 0.760 |
Why?
|
Cerebrovascular Circulation | 11 | 2015 | 70 | 0.760 |
Why?
|
Neurotransmitter Agents | 3 | 2020 | 63 | 0.760 |
Why?
|
Lewy Body Disease | 7 | 2023 | 14 | 0.760 |
Why?
|
Leptin | 4 | 2015 | 118 | 0.750 |
Why?
|
Writing | 1 | 2020 | 37 | 0.750 |
Why?
|
Microtubule-Associated Proteins | 19 | 2018 | 85 | 0.730 |
Why?
|
Glucose | 5 | 2018 | 230 | 0.730 |
Why?
|
Tubulin | 5 | 2018 | 88 | 0.730 |
Why?
|
Lipids | 5 | 2020 | 235 | 0.730 |
Why?
|
Immunologic Factors | 1 | 2020 | 45 | 0.720 |
Why?
|
Intermediate Filaments | 14 | 1991 | 19 | 0.720 |
Why?
|
Dementia, Vascular | 4 | 2012 | 36 | 0.720 |
Why?
|
Case-Control Studies | 24 | 2017 | 1130 | 0.710 |
Why?
|
Alzheimer Vaccines | 4 | 2006 | 4 | 0.710 |
Why?
|
Biological Products | 2 | 2022 | 71 | 0.710 |
Why?
|
Erythrocytes | 8 | 2013 | 111 | 0.700 |
Why?
|
Plant Extracts | 3 | 2021 | 286 | 0.700 |
Why?
|
Axonal Transport | 5 | 2018 | 10 | 0.700 |
Why?
|
Stroke | 3 | 2023 | 286 | 0.700 |
Why?
|
Apolipoprotein E4 | 7 | 2018 | 47 | 0.700 |
Why?
|
Inclusion Bodies | 12 | 2010 | 33 | 0.690 |
Why?
|
Base Sequence | 14 | 2021 | 997 | 0.690 |
Why?
|
Brain Injuries | 3 | 2019 | 121 | 0.690 |
Why?
|
Chelation Therapy | 4 | 2012 | 4 | 0.690 |
Why?
|
Signal Transduction | 27 | 2019 | 1908 | 0.680 |
Why?
|
Cerebral Arteries | 9 | 2007 | 24 | 0.680 |
Why?
|
Anti-Inflammatory Agents | 2 | 2020 | 149 | 0.670 |
Why?
|
Aquaporin 3 | 1 | 2019 | 3 | 0.670 |
Why?
|
Models, Biological | 23 | 2016 | 677 | 0.670 |
Why?
|
Erythrocyte Membrane | 1 | 2019 | 20 | 0.670 |
Why?
|
Amyloid Precursor Protein Secretases | 12 | 2015 | 33 | 0.670 |
Why?
|
Drug Design | 4 | 2023 | 162 | 0.670 |
Why?
|
Glycerol | 1 | 2019 | 28 | 0.660 |
Why?
|
Axons | 9 | 2016 | 108 | 0.660 |
Why?
|
Diabetes Mellitus, Type 2 | 5 | 2023 | 643 | 0.660 |
Why?
|
Endothelium, Vascular | 14 | 2004 | 237 | 0.650 |
Why?
|
Neuroblastoma | 22 | 2019 | 129 | 0.650 |
Why?
|
Gait | 1 | 2019 | 25 | 0.650 |
Why?
|
Endothelin-1 | 4 | 2015 | 55 | 0.650 |
Why?
|
Cattle | 4 | 2020 | 477 | 0.650 |
Why?
|
Glucose Transporter Type 3 | 1 | 2018 | 3 | 0.650 |
Why?
|
Gene Expression Regulation | 20 | 2018 | 1015 | 0.650 |
Why?
|
Lysine | 11 | 2013 | 113 | 0.640 |
Why?
|
Bacteria | 2 | 2020 | 255 | 0.640 |
Why?
|
Sex Factors | 3 | 2021 | 898 | 0.640 |
Why?
|
Transfer RNA Aminoacylation | 1 | 2018 | 1 | 0.640 |
Why?
|
Coronavirus Infections | 1 | 2020 | 68 | 0.630 |
Why?
|
Histocytochemistry | 11 | 2012 | 50 | 0.630 |
Why?
|
Pneumonia, Viral | 1 | 2020 | 76 | 0.630 |
Why?
|
Xylose | 1 | 2017 | 11 | 0.610 |
Why?
|
Rats | 49 | 2022 | 3483 | 0.610 |
Why?
|
MicroRNAs | 2 | 2020 | 426 | 0.610 |
Why?
|
Symporters | 1 | 2017 | 11 | 0.610 |
Why?
|
Cognition Disorders | 9 | 2018 | 233 | 0.610 |
Why?
|
Olfactory Bulb | 1 | 2018 | 48 | 0.600 |
Why?
|
Gastrointestinal Tract | 1 | 2018 | 61 | 0.600 |
Why?
|
Molecular Dynamics Simulation | 7 | 2018 | 133 | 0.600 |
Why?
|
Aspartic Acid Endopeptidases | 10 | 2012 | 19 | 0.600 |
Why?
|
Lipid Bilayers | 1 | 2018 | 68 | 0.600 |
Why?
|
GTP Phosphohydrolases | 7 | 2018 | 30 | 0.590 |
Why?
|
Body Fluids | 1 | 2017 | 17 | 0.590 |
Why?
|
Sequence Analysis, DNA | 7 | 2021 | 474 | 0.590 |
Why?
|
Boxing | 1 | 2017 | 1 | 0.590 |
Why?
|
Sodium Chloride | 1 | 2017 | 55 | 0.590 |
Why?
|
Prions | 7 | 2012 | 25 | 0.580 |
Why?
|
Heart | 1 | 2018 | 180 | 0.580 |
Why?
|
History, 21st Century | 8 | 2015 | 81 | 0.580 |
Why?
|
Marine Biology | 1 | 2016 | 7 | 0.580 |
Why?
|
Ferrosoferric Oxide | 2 | 2016 | 11 | 0.570 |
Why?
|
Cation Transport Proteins | 2 | 2016 | 34 | 0.570 |
Why?
|
Adult | 54 | 2022 | 11712 | 0.570 |
Why?
|
History, 20th Century | 8 | 2015 | 117 | 0.570 |
Why?
|
Amyotrophic Lateral Sclerosis | 9 | 2024 | 46 | 0.570 |
Why?
|
Iron Overload | 1 | 2016 | 8 | 0.560 |
Why?
|
Sciatic Nerve | 4 | 2013 | 11 | 0.560 |
Why?
|
Zinc | 8 | 2018 | 128 | 0.560 |
Why?
|
Cytokines | 5 | 2018 | 602 | 0.560 |
Why?
|
Research | 2 | 2013 | 163 | 0.550 |
Why?
|
Escherichia coli Proteins | 1 | 2017 | 126 | 0.550 |
Why?
|
Disease Progression | 19 | 2019 | 601 | 0.550 |
Why?
|
Apoptosis | 18 | 2012 | 1398 | 0.550 |
Why?
|
Genetics, Medical | 1 | 2016 | 6 | 0.550 |
Why?
|
Cell Death | 17 | 2018 | 267 | 0.540 |
Why?
|
Nutritional Status | 1 | 2017 | 116 | 0.540 |
Why?
|
Temporal Lobe | 11 | 2003 | 21 | 0.540 |
Why?
|
Prion Diseases | 6 | 2010 | 9 | 0.540 |
Why?
|
Protein Binding | 15 | 2020 | 972 | 0.530 |
Why?
|
Opioid-Related Disorders | 1 | 2018 | 125 | 0.530 |
Why?
|
Cell Cycle | 11 | 2019 | 326 | 0.520 |
Why?
|
Polymorphism, Single Nucleotide | 8 | 2023 | 767 | 0.520 |
Why?
|
Astrocytes | 15 | 2012 | 255 | 0.520 |
Why?
|
Synapses | 8 | 2023 | 180 | 0.510 |
Why?
|
Phytotherapy | 1 | 2015 | 81 | 0.510 |
Why?
|
Antibodies | 15 | 2013 | 141 | 0.510 |
Why?
|
Journalism, Medical | 1 | 2015 | 5 | 0.510 |
Why?
|
Fibroblast Growth Factor 2 | 7 | 2002 | 43 | 0.510 |
Why?
|
Luteinizing Hormone | 11 | 2015 | 63 | 0.510 |
Why?
|
Microtubules | 9 | 2010 | 120 | 0.500 |
Why?
|
Chemistry, Pharmaceutical | 2 | 2012 | 71 | 0.500 |
Why?
|
Particulate Matter | 1 | 2015 | 51 | 0.500 |
Why?
|
Indoles | 5 | 2021 | 158 | 0.500 |
Why?
|
Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization | 4 | 2020 | 103 | 0.500 |
Why?
|
Pregnancy Rate | 2 | 2020 | 13 | 0.500 |
Why?
|
Antibodies, Monoclonal | 19 | 2023 | 290 | 0.500 |
Why?
|
Neoplasms | 3 | 2023 | 1103 | 0.490 |
Why?
|
Mitogen-Activated Protein Kinases | 14 | 2008 | 136 | 0.490 |
Why?
|
Ceruloplasmin | 5 | 2013 | 15 | 0.490 |
Why?
|
Pathology | 2 | 2011 | 7 | 0.480 |
Why?
|
Plasmodium falciparum | 4 | 2016 | 135 | 0.480 |
Why?
|
Binding Sites | 10 | 2018 | 651 | 0.480 |
Why?
|
Supranuclear Palsy, Progressive | 10 | 2021 | 12 | 0.480 |
Why?
|
DNA Repair | 3 | 2012 | 188 | 0.470 |
Why?
|
Gene Deletion | 2 | 2007 | 166 | 0.470 |
Why?
|
Vitamin D Deficiency | 1 | 2015 | 105 | 0.470 |
Why?
|
Olfactory Mucosa | 2 | 2004 | 18 | 0.460 |
Why?
|
Informed Consent | 1 | 2014 | 31 | 0.460 |
Why?
|
Tyrosine | 10 | 2004 | 118 | 0.460 |
Why?
|
Cells, Cultured | 29 | 2018 | 1518 | 0.460 |
Why?
|
Child | 21 | 2022 | 3131 | 0.460 |
Why?
|
Serum Amyloid P-Component | 5 | 2002 | 20 | 0.460 |
Why?
|
Neuroglia | 8 | 2021 | 124 | 0.460 |
Why?
|
Chronic Disease | 2 | 2017 | 484 | 0.460 |
Why?
|
Oxygen | 8 | 2008 | 207 | 0.450 |
Why?
|
Pregnancy, Animal | 1 | 2013 | 16 | 0.450 |
Why?
|
Molecular Sequence Data | 17 | 2013 | 1568 | 0.450 |
Why?
|
Drug Delivery Systems | 4 | 2019 | 202 | 0.440 |
Why?
|
RNA, Messenger | 17 | 2018 | 1207 | 0.440 |
Why?
|
Depressive Disorder, Major | 1 | 2014 | 103 | 0.440 |
Why?
|
Heme Oxygenase-1 | 15 | 2010 | 51 | 0.440 |
Why?
|
Muscle, Skeletal | 4 | 2018 | 282 | 0.430 |
Why?
|
Technology, Pharmaceutical | 2 | 2012 | 27 | 0.430 |
Why?
|
Diet | 8 | 2023 | 801 | 0.430 |
Why?
|
Huntington Disease | 8 | 2013 | 27 | 0.430 |
Why?
|
Cytoplasm | 16 | 2009 | 143 | 0.430 |
Why?
|
Microscopy, Immunoelectron | 15 | 2011 | 34 | 0.430 |
Why?
|
Vaccination | 4 | 2013 | 288 | 0.430 |
Why?
|
Genome-Wide Association Study | 3 | 2024 | 333 | 0.420 |
Why?
|
Homeostasis | 12 | 2010 | 188 | 0.420 |
Why?
|
Erythroblastosis, Fetal | 1 | 2012 | 1 | 0.420 |
Why?
|
Rh-Hr Blood-Group System | 1 | 2012 | 4 | 0.420 |
Why?
|
Microglia | 13 | 2021 | 166 | 0.420 |
Why?
|
Lewy Bodies | 6 | 2017 | 30 | 0.420 |
Why?
|
Nanomedicine | 1 | 2012 | 35 | 0.410 |
Why?
|
Immunotherapy | 5 | 2023 | 95 | 0.410 |
Why?
|
Darkness | 1 | 2011 | 27 | 0.410 |
Why?
|
Aorta, Abdominal | 2 | 2003 | 9 | 0.410 |
Why?
|
Drug Carriers | 2 | 2012 | 125 | 0.410 |
Why?
|
Down Syndrome | 8 | 2014 | 29 | 0.400 |
Why?
|
Metabolic Diseases | 3 | 2018 | 33 | 0.400 |
Why?
|
Decision Making | 1 | 2014 | 203 | 0.400 |
Why?
|
Transfection | 18 | 2018 | 523 | 0.400 |
Why?
|
Sequence Analysis, RNA | 1 | 2011 | 106 | 0.390 |
Why?
|
Species Specificity | 7 | 2011 | 245 | 0.390 |
Why?
|
Gene Expression Profiling | 4 | 2024 | 626 | 0.380 |
Why?
|
Oxidants | 3 | 2009 | 45 | 0.380 |
Why?
|
Chemoprevention | 2 | 2017 | 35 | 0.380 |
Why?
|
Carrier Proteins | 8 | 2010 | 305 | 0.380 |
Why?
|
Rod Opsins | 2 | 2008 | 15 | 0.380 |
Why?
|
Movement Disorders | 2 | 2019 | 8 | 0.370 |
Why?
|
Disease Susceptibility | 3 | 2023 | 97 | 0.370 |
Why?
|
Epitopes | 14 | 2005 | 148 | 0.370 |
Why?
|
Contrast Media | 2 | 2018 | 92 | 0.370 |
Why?
|
Adaptation, Biological | 2 | 2021 | 24 | 0.370 |
Why?
|
Diagnostic Imaging | 1 | 2011 | 53 | 0.370 |
Why?
|
Gene Expression | 11 | 2018 | 674 | 0.370 |
Why?
|
DNA-Binding Proteins | 6 | 2024 | 539 | 0.360 |
Why?
|
Estrogens | 9 | 2020 | 202 | 0.360 |
Why?
|
Periodicals as Topic | 1 | 2011 | 49 | 0.360 |
Why?
|
Risk Factors | 15 | 2018 | 3562 | 0.360 |
Why?
|
Melatonin | 6 | 2015 | 82 | 0.360 |
Why?
|
Blood-Brain Barrier | 11 | 2018 | 162 | 0.360 |
Why?
|
Feces | 1 | 2010 | 111 | 0.360 |
Why?
|
Nitric Oxide | 5 | 2007 | 316 | 0.360 |
Why?
|
Adolescent | 25 | 2016 | 5363 | 0.360 |
Why?
|
Pathology, Clinical | 1 | 2009 | 4 | 0.360 |
Why?
|
Endopeptidases | 6 | 2006 | 59 | 0.360 |
Why?
|
Protein Precursors | 8 | 1996 | 61 | 0.350 |
Why?
|
Monosaccharide Transport Proteins | 6 | 1993 | 15 | 0.350 |
Why?
|
Tropomyosin | 6 | 1993 | 15 | 0.350 |
Why?
|
Models, Genetic | 3 | 2008 | 172 | 0.350 |
Why?
|
Immunoenzyme Techniques | 20 | 2008 | 108 | 0.350 |
Why?
|
Mice, Inbred C57BL | 17 | 2019 | 1609 | 0.350 |
Why?
|
Awards and Prizes | 1 | 2009 | 29 | 0.340 |
Why?
|
Ubiquitins | 12 | 1998 | 46 | 0.340 |
Why?
|
Time Factors | 18 | 2018 | 1742 | 0.340 |
Why?
|
Kinetics | 6 | 2017 | 708 | 0.340 |
Why?
|
Chelating Agents | 6 | 2012 | 57 | 0.340 |
Why?
|
Gonadotropins | 8 | 2008 | 27 | 0.330 |
Why?
|
Fibroblasts | 4 | 2017 | 272 | 0.330 |
Why?
|
Color Vision | 1 | 2008 | 7 | 0.330 |
Why?
|
Hematopoietic Stem Cell Mobilization | 1 | 2008 | 2 | 0.330 |
Why?
|
Superoxide Dismutase | 9 | 2013 | 155 | 0.330 |
Why?
|
Parathyroid Hormone | 1 | 2008 | 37 | 0.320 |
Why?
|
Muscular Atrophy | 2 | 2018 | 13 | 0.320 |
Why?
|
Growth Hormone | 2 | 2018 | 31 | 0.320 |
Why?
|
Enzyme Activation | 20 | 2016 | 444 | 0.320 |
Why?
|
Granulocyte Colony-Stimulating Factor | 1 | 2008 | 41 | 0.320 |
Why?
|
Hematopoietic Stem Cells | 1 | 2008 | 43 | 0.320 |
Why?
|
Tandem Repeat Sequences | 1 | 2008 | 9 | 0.320 |
Why?
|
Protein Conformation | 7 | 2017 | 389 | 0.320 |
Why?
|
Nootropic Agents | 3 | 2015 | 7 | 0.310 |
Why?
|
Treatment Failure | 2 | 2012 | 64 | 0.310 |
Why?
|
Ischemia | 1 | 2008 | 46 | 0.310 |
Why?
|
Cell Line | 12 | 2018 | 1354 | 0.310 |
Why?
|
Dietary Supplements | 6 | 2020 | 208 | 0.310 |
Why?
|
Electron Transport Complex IV | 6 | 2011 | 37 | 0.310 |
Why?
|
Mitochondrial Diseases | 4 | 2012 | 16 | 0.310 |
Why?
|
Hydrogen Peroxide | 11 | 2013 | 190 | 0.310 |
Why?
|
alpha-Amylases | 1 | 2007 | 6 | 0.310 |
Why?
|
RNA, Ribosomal | 3 | 2011 | 25 | 0.310 |
Why?
|
Systems Biology | 2 | 2021 | 22 | 0.300 |
Why?
|
Chlamydia Infections | 2 | 2015 | 196 | 0.300 |
Why?
|
Insulin | 4 | 2012 | 236 | 0.300 |
Why?
|
Color Perception | 1 | 2007 | 17 | 0.300 |
Why?
|
Nitric Oxide Synthase | 7 | 2006 | 128 | 0.300 |
Why?
|
Cell Survival | 15 | 2015 | 864 | 0.300 |
Why?
|
Neovascularization, Physiologic | 2 | 2008 | 73 | 0.300 |
Why?
|
Endothelial Cells | 2 | 2008 | 308 | 0.290 |
Why?
|
Microcirculation | 7 | 2008 | 37 | 0.290 |
Why?
|
Chromosomes, Human, Y | 1 | 2007 | 15 | 0.290 |
Why?
|
Deoxyguanosine | 3 | 2003 | 35 | 0.290 |
Why?
|
Acetylcysteine | 1 | 2007 | 62 | 0.290 |
Why?
|
Obesity | 1 | 2015 | 1067 | 0.290 |
Why?
|
Gonadotropin-Releasing Hormone | 4 | 2020 | 33 | 0.290 |
Why?
|
Sex Characteristics | 5 | 2014 | 230 | 0.290 |
Why?
|
Calcium-Calmodulin-Dependent Protein Kinases | 5 | 2002 | 40 | 0.280 |
Why?
|
Leuprolide | 4 | 2015 | 8 | 0.280 |
Why?
|
Paraffin Embedding | 2 | 2020 | 12 | 0.280 |
Why?
|
Brain Neoplasms | 4 | 2006 | 111 | 0.280 |
Why?
|
Tryptamines | 2 | 2018 | 7 | 0.280 |
Why?
|
Reference Values | 17 | 2004 | 212 | 0.280 |
Why?
|
Diabetes Mellitus | 4 | 2012 | 485 | 0.280 |
Why?
|
PrPC Proteins | 5 | 2011 | 5 | 0.280 |
Why?
|
Cholinesterase Inhibitors | 6 | 2015 | 43 | 0.280 |
Why?
|
Myositis, Inclusion Body | 1 | 2006 | 2 | 0.270 |
Why?
|
Brain Diseases | 5 | 2010 | 32 | 0.270 |
Why?
|
MSX1 Transcription Factor | 1 | 2005 | 1 | 0.270 |
Why?
|
Mass Screening | 2 | 2022 | 462 | 0.270 |
Why?
|
PAX9 Transcription Factor | 1 | 2005 | 4 | 0.270 |
Why?
|
Butyrylcholinesterase | 2 | 2018 | 5 | 0.270 |
Why?
|
Protein Multimerization | 2 | 2017 | 103 | 0.270 |
Why?
|
Streptozocin | 3 | 2022 | 21 | 0.260 |
Why?
|
Ovum | 6 | 1988 | 35 | 0.260 |
Why?
|
Cell Line, Tumor | 16 | 2019 | 2231 | 0.260 |
Why?
|
Acetylcholinesterase | 2 | 2018 | 55 | 0.260 |
Why?
|
Oligonucleotide Array Sequence Analysis | 7 | 2017 | 306 | 0.260 |
Why?
|
Heparin | 2 | 2003 | 35 | 0.250 |
Why?
|
Minority Groups | 2 | 2021 | 596 | 0.250 |
Why?
|
Hibernation | 4 | 2008 | 7 | 0.250 |
Why?
|
p38 Mitogen-Activated Protein Kinases | 11 | 2009 | 95 | 0.250 |
Why?
|
Research Design | 4 | 2021 | 313 | 0.250 |
Why?
|
Trypsin | 2 | 1996 | 38 | 0.250 |
Why?
|
Presenilin-1 | 6 | 2016 | 27 | 0.250 |
Why?
|
Chromosome Mapping | 5 | 2021 | 188 | 0.250 |
Why?
|
JNK Mitogen-Activated Protein Kinases | 10 | 2009 | 77 | 0.250 |
Why?
|
United States | 9 | 2024 | 4223 | 0.250 |
Why?
|
Trace Elements | 2 | 2002 | 30 | 0.250 |
Why?
|
Cell Movement | 1 | 2008 | 571 | 0.250 |
Why?
|
Neuropsychological Tests | 2 | 2022 | 259 | 0.250 |
Why?
|
Mexico | 5 | 2020 | 240 | 0.250 |
Why?
|
Antibody Specificity | 8 | 2005 | 79 | 0.250 |
Why?
|
Longevity | 2 | 2021 | 147 | 0.250 |
Why?
|
Malondialdehyde | 5 | 2013 | 41 | 0.240 |
Why?
|
Flavonoids | 2 | 2019 | 87 | 0.240 |
Why?
|
Dose-Response Relationship, Drug | 13 | 2017 | 1039 | 0.240 |
Why?
|
Wound Healing | 2 | 2012 | 70 | 0.240 |
Why?
|
Mitochondrial Membranes | 2 | 2023 | 40 | 0.240 |
Why?
|
Sp3 Transcription Factor | 1 | 2013 | 8 | 0.240 |
Why?
|
Frontotemporal Dementia | 1 | 2024 | 4 | 0.240 |
Why?
|
Eye | 2 | 2018 | 71 | 0.240 |
Why?
|
Genetic Predisposition to Disease | 4 | 2023 | 628 | 0.240 |
Why?
|
Adipocytes, Brown | 1 | 2013 | 8 | 0.230 |
Why?
|
Cross-Linking Reagents | 7 | 2005 | 51 | 0.230 |
Why?
|
Glycosylation | 10 | 2007 | 100 | 0.230 |
Why?
|
Ion Channels | 2 | 2013 | 71 | 0.230 |
Why?
|
Cholesterol | 4 | 2011 | 205 | 0.230 |
Why?
|
HLA-DR4 Antigen | 1 | 2013 | 20 | 0.230 |
Why?
|
Magnetic Resonance Imaging | 3 | 2023 | 481 | 0.230 |
Why?
|
Sp1 Transcription Factor | 1 | 2013 | 48 | 0.230 |
Why?
|
Heparitin Sulfate | 3 | 2007 | 23 | 0.230 |
Why?
|
Mitosis | 7 | 2006 | 99 | 0.230 |
Why?
|
Enzyme Inhibitors | 10 | 2011 | 433 | 0.230 |
Why?
|
Arteriosclerosis | 4 | 2004 | 36 | 0.230 |
Why?
|
Glucosephosphate Dehydrogenase | 2 | 2001 | 16 | 0.230 |
Why?
|
Retina | 2 | 2024 | 280 | 0.230 |
Why?
|
Neuropil | 3 | 2003 | 6 | 0.230 |
Why?
|
Air Pollution | 2 | 2016 | 60 | 0.230 |
Why?
|
Aortic Diseases | 1 | 2003 | 27 | 0.220 |
Why?
|
Epitopes, T-Lymphocyte | 1 | 2013 | 57 | 0.220 |
Why?
|
beta-Defensins | 2 | 2013 | 4 | 0.220 |
Why?
|
Amino Acid Sequence | 10 | 2018 | 1180 | 0.220 |
Why?
|
Mutation | 12 | 2017 | 1095 | 0.220 |
Why?
|
Russia | 1 | 2023 | 25 | 0.220 |
Why?
|
Acclimatization | 2 | 2023 | 21 | 0.220 |
Why?
|
Liver | 6 | 2015 | 479 | 0.220 |
Why?
|
Edema | 1 | 2023 | 23 | 0.220 |
Why?
|
Glutathione | 6 | 2017 | 179 | 0.220 |
Why?
|
Memory Disorders | 2 | 2022 | 73 | 0.220 |
Why?
|
Antigens | 7 | 2008 | 56 | 0.220 |
Why?
|
Cultural Diversity | 2 | 2021 | 169 | 0.220 |
Why?
|
Cerebral Amyloid Angiopathy | 4 | 2004 | 17 | 0.220 |
Why?
|
Methionine | 3 | 2013 | 30 | 0.220 |
Why?
|
Child, Preschool | 13 | 2016 | 1418 | 0.220 |
Why?
|
Receptors, Metabotropic Glutamate | 4 | 2008 | 28 | 0.220 |
Why?
|
Ribosomes | 2 | 2017 | 32 | 0.220 |
Why?
|
Water | 4 | 2016 | 296 | 0.210 |
Why?
|
Amino Acids | 3 | 2021 | 145 | 0.210 |
Why?
|
Autopsy | 7 | 2019 | 43 | 0.210 |
Why?
|
Sequence Alignment | 5 | 2018 | 265 | 0.210 |
Why?
|
Paleopathology | 1 | 2022 | 1 | 0.210 |
Why?
|
History, Ancient | 1 | 2022 | 12 | 0.210 |
Why?
|
Bacterial Vaccines | 1 | 2013 | 125 | 0.210 |
Why?
|
Lipid Peroxides | 4 | 2000 | 17 | 0.210 |
Why?
|
Frontal Lobe | 8 | 2012 | 48 | 0.210 |
Why?
|
Tissue Fixation | 2 | 2020 | 17 | 0.210 |
Why?
|
Calcium-Binding Proteins | 3 | 2019 | 76 | 0.210 |
Why?
|
Inflammation | 4 | 2024 | 618 | 0.210 |
Why?
|
Synaptic Transmission | 2 | 2018 | 146 | 0.210 |
Why?
|
Europe | 1 | 2022 | 101 | 0.210 |
Why?
|
Estradiol | 2 | 2020 | 262 | 0.210 |
Why?
|
Growth Inhibitors | 1 | 2001 | 26 | 0.200 |
Why?
|
Gallium | 1 | 2021 | 2 | 0.200 |
Why?
|
Rats, Wistar | 8 | 2018 | 233 | 0.200 |
Why?
|
Pyrroles | 7 | 2000 | 55 | 0.200 |
Why?
|
Antirheumatic Agents | 1 | 2021 | 31 | 0.200 |
Why?
|
Isoenzymes | 6 | 2009 | 161 | 0.200 |
Why?
|
Panama | 1 | 2021 | 5 | 0.200 |
Why?
|
Analysis of Variance | 6 | 2017 | 550 | 0.200 |
Why?
|
Publications | 1 | 2021 | 7 | 0.200 |
Why?
|
Cebus | 1 | 2021 | 4 | 0.200 |
Why?
|
Fragaria | 1 | 2021 | 1 | 0.200 |
Why?
|
Arthritis, Rheumatoid | 1 | 2021 | 43 | 0.190 |
Why?
|
Toll-Like Receptors | 2 | 2020 | 51 | 0.190 |
Why?
|
Caregivers | 1 | 2024 | 182 | 0.190 |
Why?
|
Research Personnel | 2 | 2019 | 155 | 0.190 |
Why?
|
Electrons | 1 | 2021 | 68 | 0.190 |
Why?
|
Metagenomics | 1 | 2021 | 34 | 0.190 |
Why?
|
Gliosis | 6 | 2021 | 24 | 0.190 |
Why?
|
Phenylhydrazines | 4 | 2000 | 4 | 0.190 |
Why?
|
Sleep | 1 | 2023 | 152 | 0.190 |
Why?
|
Sea Urchins | 5 | 1985 | 9 | 0.190 |
Why?
|
Caribbean Region | 1 | 2021 | 69 | 0.190 |
Why?
|
Microscopy, Electron, Transmission | 6 | 2016 | 146 | 0.190 |
Why?
|
DNA Fingerprinting | 2 | 2019 | 18 | 0.190 |
Why?
|
Lymphocytes | 3 | 2021 | 118 | 0.190 |
Why?
|
Measles-Mumps-Rubella Vaccine | 1 | 2020 | 4 | 0.190 |
Why?
|
Norleucine | 5 | 2000 | 5 | 0.190 |
Why?
|
Guidelines as Topic | 2 | 2014 | 54 | 0.190 |
Why?
|
Tryptophan-tRNA Ligase | 2 | 2018 | 2 | 0.190 |
Why?
|
Biological Transport | 6 | 2016 | 185 | 0.190 |
Why?
|
Blotting, Western | 14 | 2015 | 859 | 0.190 |
Why?
|
Drug Evaluation, Preclinical | 3 | 2017 | 112 | 0.190 |
Why?
|
Lactoferrin | 1 | 2020 | 4 | 0.190 |
Why?
|
Salivary Glands | 1 | 2020 | 12 | 0.190 |
Why?
|
Insemination, Artificial | 1 | 2020 | 9 | 0.190 |
Why?
|
Calcium | 7 | 2024 | 480 | 0.190 |
Why?
|
Haplotypes | 1 | 2021 | 182 | 0.180 |
Why?
|
Blood Vessels | 4 | 2004 | 34 | 0.180 |
Why?
|
Glial Fibrillary Acidic Protein | 9 | 2022 | 70 | 0.180 |
Why?
|
Genotype | 7 | 2012 | 730 | 0.180 |
Why?
|
Life Style | 2 | 2019 | 308 | 0.180 |
Why?
|
Veterans | 1 | 2021 | 122 | 0.180 |
Why?
|
Histidine | 3 | 2010 | 42 | 0.180 |
Why?
|
Arginine | 5 | 2000 | 73 | 0.180 |
Why?
|
Creutzfeldt-Jakob Syndrome | 2 | 2013 | 28 | 0.180 |
Why?
|
Early Diagnosis | 2 | 2018 | 64 | 0.180 |
Why?
|
Rabbits | 8 | 2006 | 283 | 0.180 |
Why?
|
Vagina | 1 | 2020 | 81 | 0.180 |
Why?
|
Protein Disulfide-Isomerases | 1 | 2000 | 12 | 0.180 |
Why?
|
Lipofuscin | 2 | 2011 | 4 | 0.180 |
Why?
|
Transcription Factors | 3 | 2018 | 681 | 0.180 |
Why?
|
Excitatory Amino Acid Antagonists | 5 | 2011 | 99 | 0.180 |
Why?
|
TDP-43 Proteinopathies | 1 | 2019 | 1 | 0.180 |
Why?
|
Biological Specimen Banks | 1 | 2020 | 25 | 0.180 |
Why?
|
Regeneration | 1 | 1999 | 20 | 0.180 |
Why?
|
DNA Degradation, Necrotic | 1 | 2019 | 1 | 0.170 |
Why?
|
Ginkgo biloba | 1 | 2019 | 3 | 0.170 |
Why?
|
Gene Flow | 1 | 2019 | 14 | 0.170 |
Why?
|
Rats, Sprague-Dawley | 11 | 2018 | 1618 | 0.170 |
Why?
|
Postmortem Changes | 8 | 2012 | 18 | 0.170 |
Why?
|
Sulfhydryl Compounds | 1 | 1999 | 47 | 0.170 |
Why?
|
Muscles | 4 | 1994 | 82 | 0.170 |
Why?
|
Microsatellite Repeats | 1 | 2019 | 59 | 0.170 |
Why?
|
Brain Stem | 3 | 2011 | 50 | 0.170 |
Why?
|
Nitrates | 3 | 2003 | 40 | 0.170 |
Why?
|
Matrix Metalloproteinase 9 | 1 | 2020 | 90 | 0.170 |
Why?
|
Tissue Distribution | 7 | 2014 | 207 | 0.170 |
Why?
|
Sterol Regulatory Element Binding Protein 2 | 1 | 2019 | 5 | 0.170 |
Why?
|
Intracellular Signaling Peptides and Proteins | 2 | 2010 | 187 | 0.170 |
Why?
|
Forensic Pathology | 1 | 2019 | 2 | 0.170 |
Why?
|
Lithium Chloride | 1 | 2019 | 4 | 0.170 |
Why?
|
Post-Concussion Syndrome | 1 | 2019 | 4 | 0.170 |
Why?
|
Physicians | 1 | 2021 | 163 | 0.170 |
Why?
|
Antimanic Agents | 1 | 2019 | 4 | 0.170 |
Why?
|
Hydrolases | 1 | 1998 | 15 | 0.170 |
Why?
|
Cell Membrane Permeability | 2 | 2019 | 52 | 0.170 |
Why?
|
Acetylglucosamine | 1 | 2018 | 7 | 0.170 |
Why?
|
Amidohydrolases | 1 | 1998 | 11 | 0.170 |
Why?
|
Communication | 1 | 2020 | 180 | 0.170 |
Why?
|
Cardiovascular Diseases | 2 | 2023 | 664 | 0.170 |
Why?
|
Image Processing, Computer-Assisted | 4 | 2011 | 173 | 0.170 |
Why?
|
In Situ Hybridization | 6 | 2008 | 129 | 0.170 |
Why?
|
Mass Spectrometry | 2 | 2018 | 260 | 0.160 |
Why?
|
Leukocytes, Mononuclear | 2 | 2019 | 234 | 0.160 |
Why?
|
Behavioral Research | 1 | 2019 | 39 | 0.160 |
Why?
|
Calcium Compounds | 1 | 2018 | 4 | 0.160 |
Why?
|
Calpain | 1 | 2019 | 35 | 0.160 |
Why?
|
Facilitated Diffusion | 1 | 2018 | 2 | 0.160 |
Why?
|
Tumor Cells, Cultured | 13 | 2005 | 502 | 0.160 |
Why?
|
Polymorphism, Genetic | 2 | 2010 | 191 | 0.160 |
Why?
|
Keratins | 5 | 1991 | 25 | 0.160 |
Why?
|
Endoplasmic Reticulum | 4 | 2015 | 105 | 0.160 |
Why?
|
Mortality | 1 | 2020 | 145 | 0.160 |
Why?
|
Occipital Lobe | 1 | 1998 | 5 | 0.160 |
Why?
|
Risk Assessment | 2 | 2019 | 753 | 0.160 |
Why?
|
Choroid Plexus | 3 | 2013 | 6 | 0.160 |
Why?
|
Ethanol | 1 | 2020 | 192 | 0.160 |
Why?
|
Theta Rhythm | 1 | 2018 | 7 | 0.160 |
Why?
|
Immune Sera | 8 | 2003 | 59 | 0.160 |
Why?
|
Chorion | 1 | 2018 | 8 | 0.160 |
Why?
|
Iron-Sulfur Proteins | 1 | 1998 | 15 | 0.160 |
Why?
|
Minority Health | 1 | 2019 | 88 | 0.160 |
Why?
|
Brain Concussion | 1 | 2019 | 29 | 0.160 |
Why?
|
Extracellular Signal-Regulated MAP Kinases | 2 | 2009 | 93 | 0.160 |
Why?
|
Free Radical Scavengers | 3 | 2008 | 66 | 0.160 |
Why?
|
Hypoxia-Ischemia, Brain | 2 | 2009 | 43 | 0.160 |
Why?
|
Substance Abuse Detection | 1 | 2018 | 30 | 0.160 |
Why?
|
Substantia Nigra | 3 | 1999 | 44 | 0.160 |
Why?
|
Maillard Reaction | 2 | 1994 | 6 | 0.160 |
Why?
|
Referral and Consultation | 1 | 2019 | 117 | 0.160 |
Why?
|
Heat-Shock Proteins | 4 | 2011 | 55 | 0.160 |
Why?
|
Pregnancy | 5 | 2020 | 1549 | 0.160 |
Why?
|
Depsides | 1 | 2017 | 3 | 0.160 |
Why?
|
Cell Cycle Proteins | 4 | 2009 | 229 | 0.160 |
Why?
|
rab GTP-Binding Proteins | 1 | 2018 | 12 | 0.160 |
Why?
|
Cinnamates | 1 | 2017 | 6 | 0.160 |
Why?
|
Olea | 1 | 2017 | 1 | 0.150 |
Why?
|
Stem Cell Transplantation | 1 | 2018 | 31 | 0.150 |
Why?
|
Glucose Transport Proteins, Facilitative | 1 | 2017 | 14 | 0.150 |
Why?
|
Microscopy, Electron, Scanning | 5 | 2015 | 142 | 0.150 |
Why?
|
Cerebellum | 4 | 2006 | 73 | 0.150 |
Why?
|
Capillaries | 5 | 2008 | 26 | 0.150 |
Why?
|
Military Personnel | 1 | 2019 | 90 | 0.150 |
Why?
|
Subcellular Fractions | 4 | 2004 | 77 | 0.150 |
Why?
|
Treatment Outcome | 2 | 2019 | 1369 | 0.150 |
Why?
|
Pyridones | 2 | 2009 | 40 | 0.150 |
Why?
|
Pick Disease of the Brain | 3 | 2007 | 4 | 0.150 |
Why?
|
Intermediate Filament Proteins | 5 | 1991 | 13 | 0.150 |
Why?
|
Cytoprotection | 2 | 2009 | 36 | 0.150 |
Why?
|
Plants | 2 | 2016 | 99 | 0.150 |
Why?
|
Caspase 3 | 3 | 2015 | 207 | 0.150 |
Why?
|
Spectrum Analysis | 2 | 2016 | 54 | 0.150 |
Why?
|
DNA Fragmentation | 5 | 2019 | 92 | 0.150 |
Why?
|
Databases, Bibliographic | 2 | 2015 | 9 | 0.150 |
Why?
|
Molecular Structure | 6 | 2017 | 492 | 0.150 |
Why?
|
Cytoskeletal Proteins | 4 | 1996 | 105 | 0.150 |
Why?
|
Dogs | 3 | 2016 | 149 | 0.150 |
Why?
|
Homocysteine | 3 | 2008 | 19 | 0.150 |
Why?
|
Maze Learning | 4 | 2013 | 105 | 0.150 |
Why?
|
Neurosciences | 1 | 1997 | 28 | 0.150 |
Why?
|
Anthocyanins | 1 | 2017 | 5 | 0.150 |
Why?
|
Tretinoin | 2 | 2009 | 50 | 0.150 |
Why?
|
DNA Primers | 2 | 2008 | 286 | 0.150 |
Why?
|
Biomimetic Materials | 1 | 2017 | 23 | 0.150 |
Why?
|
Estrogen Replacement Therapy | 4 | 2006 | 44 | 0.150 |
Why?
|
Membrane Transport Proteins | 3 | 2012 | 95 | 0.150 |
Why?
|
Deep Brain Stimulation | 1 | 2017 | 9 | 0.150 |
Why?
|
Mice, Inbred Strains | 3 | 2013 | 116 | 0.140 |
Why?
|
Receptors, Nicotinic | 1 | 2018 | 106 | 0.140 |
Why?
|
Stem Cells | 1 | 2018 | 141 | 0.140 |
Why?
|
Chitin | 2 | 2007 | 19 | 0.140 |
Why?
|
Terminology as Topic | 1 | 2017 | 34 | 0.140 |
Why?
|
Neuritis | 1 | 2016 | 2 | 0.140 |
Why?
|
Drug Stability | 1 | 2017 | 116 | 0.140 |
Why?
|
Estrogen Receptor alpha | 2 | 2016 | 111 | 0.140 |
Why?
|
RNA-Binding Proteins | 1 | 1998 | 146 | 0.140 |
Why?
|
Leishmania | 1 | 2016 | 17 | 0.140 |
Why?
|
Holography | 1 | 2016 | 3 | 0.140 |
Why?
|
Glycogen Synthase Kinase 3 | 3 | 2006 | 32 | 0.140 |
Why?
|
Host-Pathogen Interactions | 1 | 2018 | 186 | 0.140 |
Why?
|
Ascorbic Acid | 5 | 2017 | 66 | 0.140 |
Why?
|
Neurotoxicity Syndromes | 2 | 2007 | 35 | 0.140 |
Why?
|
Heterocyclic Compounds | 1 | 2016 | 21 | 0.140 |
Why?
|
Mice, Knockout | 7 | 2018 | 933 | 0.140 |
Why?
|
Action Potentials | 1 | 2018 | 231 | 0.140 |
Why?
|
Medicare | 1 | 2018 | 195 | 0.140 |
Why?
|
Propylene Glycols | 1 | 2016 | 4 | 0.140 |
Why?
|
Antiprotozoal Agents | 1 | 2016 | 30 | 0.140 |
Why?
|
Cohort Studies | 3 | 2015 | 1492 | 0.140 |
Why?
|
Aquaporins | 1 | 2016 | 17 | 0.140 |
Why?
|
Antineoplastic Agents, Phytogenic | 1 | 2017 | 110 | 0.140 |
Why?
|
alpha 1-Antichymotrypsin | 2 | 1993 | 2 | 0.130 |
Why?
|
Evidence-Based Medicine | 1 | 2016 | 97 | 0.130 |
Why?
|
Basal Ganglia | 1 | 1995 | 17 | 0.130 |
Why?
|
Dynamins | 5 | 2017 | 16 | 0.130 |
Why?
|
Models, Chemical | 1 | 2017 | 207 | 0.130 |
Why?
|
Fertilization | 4 | 1985 | 38 | 0.130 |
Why?
|
Polymerase Chain Reaction | 5 | 2010 | 448 | 0.130 |
Why?
|
Pharmacogenetics | 1 | 2016 | 49 | 0.130 |
Why?
|
Ribonucleases | 3 | 2005 | 30 | 0.130 |
Why?
|
Proteoglycans | 2 | 1992 | 47 | 0.130 |
Why?
|
Brain Injury, Chronic | 1 | 2015 | 1 | 0.130 |
Why?
|
Glyceraldehyde | 1 | 1995 | 3 | 0.130 |
Why?
|
Pentanoic Acids | 1 | 2015 | 2 | 0.130 |
Why?
|
Ribose | 1 | 1995 | 11 | 0.130 |
Why?
|
Solubility | 4 | 2016 | 118 | 0.130 |
Why?
|
Developing Countries | 1 | 2016 | 99 | 0.130 |
Why?
|
Cell Size | 2 | 2007 | 44 | 0.130 |
Why?
|
Chlamydophila pneumoniae | 1 | 2015 | 8 | 0.130 |
Why?
|
Communicable Diseases | 1 | 2016 | 45 | 0.130 |
Why?
|
BRCA1 Protein | 2 | 2023 | 48 | 0.130 |
Why?
|
Gonadotropins, Pituitary | 2 | 2005 | 2 | 0.130 |
Why?
|
Ubiquitin-Protein Ligases | 1 | 2015 | 75 | 0.130 |
Why?
|
Chromosomes, Human, X | 1 | 2015 | 22 | 0.130 |
Why?
|
Insulin-Secreting Cells | 1 | 2015 | 28 | 0.130 |
Why?
|
Aneuploidy | 1 | 2015 | 23 | 0.130 |
Why?
|
Hydrocephalus | 2 | 2006 | 16 | 0.130 |
Why?
|
Uric Acid | 2 | 2017 | 26 | 0.130 |
Why?
|
Fluorescent Antibody Technique | 11 | 2011 | 189 | 0.130 |
Why?
|
Reverse Transcriptase Polymerase Chain Reaction | 5 | 2013 | 623 | 0.120 |
Why?
|
Alleles | 2 | 2012 | 321 | 0.120 |
Why?
|
Drug Discovery | 2 | 2018 | 82 | 0.120 |
Why?
|
Coumarins | 1 | 2015 | 38 | 0.120 |
Why?
|
Mitogen-Activated Protein Kinase 1 | 3 | 2005 | 99 | 0.120 |
Why?
|
Mast Cells | 1 | 2015 | 81 | 0.120 |
Why?
|
Type C Phospholipases | 4 | 1995 | 21 | 0.120 |
Why?
|
Escherichia coli | 1 | 2017 | 453 | 0.120 |
Why?
|
Selenoproteins | 1 | 2017 | 159 | 0.120 |
Why?
|
Faculty, Medical | 1 | 2015 | 66 | 0.120 |
Why?
|
Young Adult | 9 | 2019 | 4268 | 0.120 |
Why?
|
Hospitalization | 1 | 2018 | 388 | 0.120 |
Why?
|
Membrane Potential, Mitochondrial | 4 | 2017 | 84 | 0.120 |
Why?
|
Hypoxia-Inducible Factor 1, alpha Subunit | 3 | 2013 | 84 | 0.120 |
Why?
|
Transition Elements | 2 | 2012 | 3 | 0.120 |
Why?
|
Mice, Inbred BALB C | 8 | 2016 | 661 | 0.120 |
Why?
|
Prefrontal Cortex | 1 | 2016 | 137 | 0.120 |
Why?
|
Body Weight | 2 | 2015 | 434 | 0.120 |
Why?
|
Recombinant Proteins | 3 | 2012 | 515 | 0.120 |
Why?
|
Nanostructures | 2 | 2006 | 134 | 0.120 |
Why?
|
Central Nervous System Diseases | 2 | 2012 | 29 | 0.120 |
Why?
|
Heme | 3 | 2005 | 70 | 0.120 |
Why?
|
Locus Coeruleus | 2 | 1996 | 15 | 0.120 |
Why?
|
Acute-Phase Proteins | 1 | 1993 | 14 | 0.120 |
Why?
|
Apolipoprotein E3 | 1 | 2013 | 10 | 0.120 |
Why?
|
Protein Structure, Secondary | 5 | 2020 | 183 | 0.120 |
Why?
|
Muscle, Smooth, Vascular | 2 | 2001 | 130 | 0.120 |
Why?
|
Cytoplasmic Granules | 2 | 2011 | 8 | 0.120 |
Why?
|
Macrophages | 2 | 2016 | 439 | 0.120 |
Why?
|
Antithrombin III | 1 | 1993 | 4 | 0.120 |
Why?
|
Protein Isoforms | 2 | 2023 | 130 | 0.120 |
Why?
|
Receptors, Leptin | 1 | 2013 | 13 | 0.120 |
Why?
|
NF-kappa B | 2 | 2010 | 339 | 0.120 |
Why?
|
Molecular Weight | 7 | 2013 | 167 | 0.120 |
Why?
|
Ischemic Attack, Transient | 1 | 1993 | 20 | 0.120 |
Why?
|
Chemokines | 1 | 2014 | 97 | 0.110 |
Why?
|
Sequence Deletion | 2 | 2004 | 87 | 0.110 |
Why?
|
In Situ Hybridization, Fluorescence | 2 | 2015 | 53 | 0.110 |
Why?
|
KCNQ2 Potassium Channel | 1 | 2013 | 3 | 0.110 |
Why?
|
Mitogen-Activated Protein Kinase Kinases | 2 | 2003 | 29 | 0.110 |
Why?
|
DNA Mutational Analysis | 3 | 2010 | 93 | 0.110 |
Why?
|
Cysteine Proteinase Inhibitors | 2 | 2005 | 22 | 0.110 |
Why?
|
Pineal Gland | 2 | 1990 | 31 | 0.110 |
Why?
|
DNA Glycosylases | 1 | 2013 | 16 | 0.110 |
Why?
|
Embryonic and Fetal Development | 1 | 1993 | 37 | 0.110 |
Why?
|
Gene Expression Regulation, Neoplastic | 1 | 2019 | 807 | 0.110 |
Why?
|
Cyclin-Dependent Kinases | 2 | 2004 | 27 | 0.110 |
Why?
|
Transferrin | 1 | 2013 | 40 | 0.110 |
Why?
|
Mammary Neoplasms, Experimental | 1 | 1993 | 70 | 0.110 |
Why?
|
Monoamine Oxidase | 1 | 2013 | 34 | 0.110 |
Why?
|
Centromere | 1 | 2013 | 21 | 0.110 |
Why?
|
Antibiotics, Antineoplastic | 1 | 2013 | 44 | 0.110 |
Why?
|
Ischemic Preconditioning | 2 | 2011 | 48 | 0.110 |
Why?
|
Infant | 6 | 2016 | 1046 | 0.110 |
Why?
|
Polymorphism, Restriction Fragment Length | 1 | 2012 | 28 | 0.110 |
Why?
|
Gene Amplification | 1 | 2012 | 26 | 0.110 |
Why?
|
Hydroxyl Radical | 4 | 2010 | 15 | 0.110 |
Why?
|
Guanine | 2 | 2003 | 45 | 0.110 |
Why?
|
Arachidonic Acids | 3 | 1988 | 24 | 0.110 |
Why?
|
Fluorescence | 1 | 2013 | 121 | 0.110 |
Why?
|
Diabetes Mellitus, Experimental | 2 | 2011 | 94 | 0.110 |
Why?
|
Caspases | 4 | 2003 | 147 | 0.110 |
Why?
|
Neuropharmacology | 2 | 2009 | 2 | 0.110 |
Why?
|
Nucleic Acid Hybridization | 3 | 2008 | 69 | 0.110 |
Why?
|
Drug Therapy, Combination | 2 | 2015 | 227 | 0.110 |
Why?
|
Blood Glucose | 2 | 2013 | 353 | 0.110 |
Why?
|
Texas | 1 | 2014 | 324 | 0.110 |
Why?
|
alpha 1-Antitrypsin | 1 | 1992 | 7 | 0.100 |
Why?
|
Presenilins | 5 | 2010 | 6 | 0.100 |
Why?
|
Animals, Newborn | 7 | 2014 | 343 | 0.100 |
Why?
|
Sensitivity and Specificity | 3 | 2023 | 562 | 0.100 |
Why?
|
Retrograde Degeneration | 1 | 2011 | 1 | 0.100 |
Why?
|
Septal Nuclei | 1 | 2011 | 3 | 0.100 |
Why?
|
Microscopy, Fluorescence | 5 | 2017 | 252 | 0.100 |
Why?
|
Madagascar | 1 | 2011 | 7 | 0.100 |
Why?
|
Endangered Species | 1 | 2011 | 10 | 0.100 |
Why?
|
Receptors, Immunologic | 2 | 2010 | 61 | 0.100 |
Why?
|
Neurobiology | 1 | 2011 | 1 | 0.100 |
Why?
|
Ribosomal Protein S6 | 1 | 2011 | 2 | 0.100 |
Why?
|
Immunoglobulin G | 2 | 2010 | 237 | 0.100 |
Why?
|
Biological Assay | 1 | 2012 | 59 | 0.100 |
Why?
|
Nucleotides | 1 | 2011 | 36 | 0.100 |
Why?
|
Antineoplastic Combined Chemotherapy Protocols | 1 | 1993 | 182 | 0.100 |
Why?
|
Antineoplastic Agents | 1 | 2019 | 803 | 0.100 |
Why?
|
Plant Lectins | 1 | 1991 | 4 | 0.100 |
Why?
|
Organometallic Compounds | 1 | 2012 | 73 | 0.100 |
Why?
|
Gene Expression Regulation, Enzymologic | 3 | 2009 | 168 | 0.100 |
Why?
|
Antimicrobial Cationic Peptides | 1 | 2012 | 35 | 0.100 |
Why?
|
Open Reading Frames | 1 | 2011 | 77 | 0.100 |
Why?
|
Cerebral Hemorrhage | 2 | 2003 | 103 | 0.100 |
Why?
|
G-Protein-Coupled Receptor Kinase 2 | 2 | 2008 | 6 | 0.100 |
Why?
|
Positron-Emission Tomography | 2 | 2023 | 80 | 0.100 |
Why?
|
Drug Compounding | 1 | 2012 | 76 | 0.100 |
Why?
|
Extracellular Space | 1 | 1991 | 35 | 0.100 |
Why?
|
Macaca mulatta | 2 | 2008 | 128 | 0.100 |
Why?
|
Hormone Replacement Therapy | 3 | 2006 | 41 | 0.100 |
Why?
|
Microtubule Proteins | 2 | 1988 | 4 | 0.100 |
Why?
|
Geography | 1 | 2011 | 96 | 0.100 |
Why?
|
Nitric Oxide Synthase Type II | 4 | 2005 | 115 | 0.100 |
Why?
|
Sciuridae | 3 | 2008 | 5 | 0.100 |
Why?
|
Retinoblastoma Protein | 1 | 2011 | 27 | 0.100 |
Why?
|
Anti-Inflammatory Agents, Non-Steroidal | 3 | 2008 | 121 | 0.100 |
Why?
|
Central Nervous System Agents | 1 | 2011 | 7 | 0.100 |
Why?
|
1-Methyl-4-phenylpyridinium | 1 | 2011 | 30 | 0.100 |
Why?
|
Pituitary Gland | 4 | 2018 | 63 | 0.100 |
Why?
|
T-Lymphocytes | 1 | 1993 | 357 | 0.090 |
Why?
|
Hypochlorous Acid | 1 | 2010 | 3 | 0.090 |
Why?
|
Substance-Related Disorders | 1 | 2018 | 730 | 0.090 |
Why?
|
Vimentin | 2 | 1990 | 37 | 0.090 |
Why?
|
Nonlinear Dynamics | 1 | 2010 | 33 | 0.090 |
Why?
|
Peptide Hydrolases | 1 | 2010 | 40 | 0.090 |
Why?
|
Fertility Agents, Female | 2 | 2007 | 6 | 0.090 |
Why?
|
Flow Cytometry | 4 | 2021 | 399 | 0.090 |
Why?
|
Mathematics | 1 | 2010 | 48 | 0.090 |
Why?
|
Actins | 5 | 2006 | 148 | 0.090 |
Why?
|
Oligodendroglioma | 1 | 1990 | 5 | 0.090 |
Why?
|
Calmodulin-Binding Proteins | 1 | 2010 | 6 | 0.090 |
Why?
|
Diet, Mediterranean | 1 | 2010 | 40 | 0.090 |
Why?
|
Neocortex | 3 | 2006 | 27 | 0.090 |
Why?
|
Microscopy, Confocal | 5 | 2015 | 218 | 0.090 |
Why?
|
Amino Acid Substitution | 2 | 2012 | 132 | 0.090 |
Why?
|
Astrocytoma | 1 | 1990 | 14 | 0.090 |
Why?
|
Antigens, Differentiation | 1 | 1990 | 25 | 0.090 |
Why?
|
Kynurenine | 1 | 2010 | 7 | 0.090 |
Why?
|
Memantine | 1 | 2009 | 4 | 0.090 |
Why?
|
Indoleamine-Pyrrole 2,3,-Dioxygenase | 1 | 2010 | 7 | 0.090 |
Why?
|
Oxidative Phosphorylation | 2 | 2010 | 53 | 0.090 |
Why?
|
Embryo, Mammalian | 5 | 2010 | 153 | 0.090 |
Why?
|
Retrospective Studies | 3 | 2021 | 2026 | 0.090 |
Why?
|
Uganda | 2 | 2019 | 22 | 0.090 |
Why?
|
Polymers | 3 | 2005 | 121 | 0.090 |
Why?
|
Rats, Inbred Strains | 5 | 2000 | 133 | 0.090 |
Why?
|
5-Aminolevulinate Synthetase | 1 | 2009 | 1 | 0.090 |
Why?
|
Infant, Newborn | 7 | 2014 | 894 | 0.090 |
Why?
|
Parkinson Disease, Secondary | 1 | 1989 | 10 | 0.090 |
Why?
|
Iron Metabolism Disorders | 1 | 2009 | 3 | 0.090 |
Why?
|
Receptors, LDL | 2 | 2012 | 30 | 0.090 |
Why?
|
MAP Kinase Kinase 4 | 4 | 2012 | 31 | 0.090 |
Why?
|
Growth | 1 | 2009 | 12 | 0.080 |
Why?
|
Infarction, Middle Cerebral Artery | 2 | 2007 | 77 | 0.080 |
Why?
|
Phlebotomy | 1 | 2009 | 5 | 0.080 |
Why?
|
Heredodegenerative Disorders, Nervous System | 1 | 2009 | 2 | 0.080 |
Why?
|
Hypoxia, Brain | 1 | 2009 | 7 | 0.080 |
Why?
|
Oxygen Consumption | 5 | 2013 | 103 | 0.080 |
Why?
|
Cell Differentiation | 4 | 2018 | 587 | 0.080 |
Why?
|
Brain Diseases, Metabolic | 1 | 1989 | 1 | 0.080 |
Why?
|
Leigh Disease | 1 | 1989 | 1 | 0.080 |
Why?
|
Glioblastoma | 1 | 1990 | 55 | 0.080 |
Why?
|
Nuclear Proteins | 4 | 2019 | 307 | 0.080 |
Why?
|
Spinal Cord Diseases | 1 | 1989 | 5 | 0.080 |
Why?
|
Peptides | 3 | 2021 | 320 | 0.080 |
Why?
|
Genes, myc | 1 | 2009 | 29 | 0.080 |
Why?
|
Carbohydrate Metabolism | 2 | 2003 | 21 | 0.080 |
Why?
|
Vacuoles | 2 | 2003 | 25 | 0.080 |
Why?
|
Cacao | 1 | 2008 | 10 | 0.080 |
Why?
|
S Phase | 1 | 2009 | 37 | 0.080 |
Why?
|
Immunoprecipitation | 2 | 2009 | 131 | 0.080 |
Why?
|
Asphyxia Neonatorum | 1 | 2008 | 5 | 0.080 |
Why?
|
Caloric Restriction | 1 | 2009 | 32 | 0.080 |
Why?
|
Blotting, Northern | 3 | 2005 | 150 | 0.080 |
Why?
|
Resuscitation | 1 | 2008 | 17 | 0.080 |
Why?
|
Filgrastim | 1 | 2008 | 2 | 0.080 |
Why?
|
Comparative Genomic Hybridization | 1 | 2008 | 17 | 0.080 |
Why?
|
Histone Deacetylases | 1 | 2009 | 56 | 0.080 |
Why?
|
Respiration, Artificial | 1 | 2008 | 39 | 0.080 |
Why?
|
Autoantibodies | 1 | 2009 | 103 | 0.080 |
Why?
|
Regional Blood Flow | 1 | 2008 | 40 | 0.080 |
Why?
|
Iron Compounds | 1 | 2008 | 4 | 0.080 |
Why?
|
Potyvirus | 1 | 2008 | 5 | 0.080 |
Why?
|
Histones | 3 | 2007 | 190 | 0.080 |
Why?
|
Mitochondria, Muscle | 2 | 2006 | 16 | 0.080 |
Why?
|
Blood Flow Velocity | 1 | 2008 | 61 | 0.080 |
Why?
|
Densitometry | 2 | 2000 | 13 | 0.080 |
Why?
|
Multiple Sclerosis | 2 | 2007 | 45 | 0.080 |
Why?
|
Staining and Labeling | 7 | 1993 | 105 | 0.080 |
Why?
|
Acetylcarnitine | 1 | 2008 | 8 | 0.080 |
Why?
|
Metal Metabolism, Inborn Errors | 1 | 2008 | 1 | 0.080 |
Why?
|
Chromosomes, Human | 1 | 2008 | 35 | 0.080 |
Why?
|
Urochordata | 1 | 1988 | 2 | 0.080 |
Why?
|
Central Nervous System | 2 | 2007 | 135 | 0.080 |
Why?
|
Stress, Psychological | 1 | 2014 | 583 | 0.080 |
Why?
|
Cysteine Endopeptidases | 4 | 2004 | 59 | 0.080 |
Why?
|
Hydrostatic Pressure | 1 | 2007 | 7 | 0.080 |
Why?
|
Demyelinating Diseases | 2 | 1998 | 15 | 0.080 |
Why?
|
Exercise | 1 | 2013 | 613 | 0.080 |
Why?
|
Eukaryotic Cells | 1 | 2007 | 36 | 0.080 |
Why?
|
Starch | 1 | 2007 | 12 | 0.080 |
Why?
|
Ubiquinone | 2 | 2010 | 22 | 0.080 |
Why?
|
Clinical Laboratory Techniques | 1 | 2007 | 26 | 0.080 |
Why?
|
Menopause | 1 | 2008 | 56 | 0.080 |
Why?
|
Retinal Diseases | 1 | 2007 | 17 | 0.080 |
Why?
|
Optic Nerve Diseases | 1 | 2007 | 26 | 0.080 |
Why?
|
Rats, Inbred F344 | 4 | 2009 | 245 | 0.080 |
Why?
|
Age Factors | 5 | 2012 | 1033 | 0.080 |
Why?
|
Permeability | 3 | 2016 | 67 | 0.080 |
Why?
|
Interleukin-6 | 2 | 2001 | 153 | 0.080 |
Why?
|
Nerve Growth Factor | 2 | 2008 | 30 | 0.080 |
Why?
|
Lithium Compounds | 1 | 2007 | 3 | 0.080 |
Why?
|
Imaging, Three-Dimensional | 1 | 2008 | 84 | 0.080 |
Why?
|
Research Support as Topic | 2 | 2019 | 80 | 0.070 |
Why?
|
Retinal Ganglion Cells | 1 | 2007 | 44 | 0.070 |
Why?
|
Organelles | 1 | 2007 | 24 | 0.070 |
Why?
|
Polysaccharides | 1 | 2007 | 58 | 0.070 |
Why?
|
Muscle Proteins | 2 | 2003 | 51 | 0.070 |
Why?
|
Data Interpretation, Statistical | 1 | 2007 | 111 | 0.070 |
Why?
|
Metabolomics | 2 | 2021 | 81 | 0.070 |
Why?
|
Proto-Oncogene Proteins c-jun | 1 | 2007 | 26 | 0.070 |
Why?
|
Kruppel-Like Transcription Factors | 1 | 2007 | 22 | 0.070 |
Why?
|
Pan paniscus | 1 | 2007 | 1 | 0.070 |
Why?
|
Xanthomatosis, Cerebrotendinous | 1 | 2007 | 1 | 0.070 |
Why?
|
Gorilla gorilla | 1 | 2007 | 4 | 0.070 |
Why?
|
Mesencephalon | 3 | 2002 | 41 | 0.070 |
Why?
|
Recombinant Fusion Proteins | 2 | 2006 | 295 | 0.070 |
Why?
|
Genomic Imprinting | 1 | 2007 | 35 | 0.070 |
Why?
|
Hypoglycemic Agents | 1 | 2009 | 160 | 0.070 |
Why?
|
Smad2 Protein | 1 | 2006 | 8 | 0.070 |
Why?
|
Hypothalamo-Hypophyseal System | 2 | 2004 | 53 | 0.070 |
Why?
|
alpha Karyopherins | 1 | 2006 | 3 | 0.070 |
Why?
|
Retinoblastoma-Like Protein p130 | 1 | 2006 | 1 | 0.070 |
Why?
|
Osteopontin | 1 | 2007 | 36 | 0.070 |
Why?
|
beta-Adrenergic Receptor Kinases | 1 | 2006 | 2 | 0.070 |
Why?
|
Immunologic Techniques | 4 | 2008 | 11 | 0.070 |
Why?
|
Enzyme-Linked Immunosorbent Assay | 4 | 2009 | 448 | 0.070 |
Why?
|
Family | 1 | 2008 | 173 | 0.070 |
Why?
|
Water Pollution, Chemical | 1 | 2006 | 10 | 0.070 |
Why?
|
Cholinergic Antagonists | 1 | 2006 | 8 | 0.070 |
Why?
|
RNA Interference | 3 | 2012 | 243 | 0.070 |
Why?
|
Spleen | 4 | 2015 | 199 | 0.070 |
Why?
|
Glaucoma | 1 | 2007 | 85 | 0.070 |
Why?
|
Catechols | 1 | 2006 | 5 | 0.070 |
Why?
|
Muscular Dystrophy, Animal | 1 | 1986 | 3 | 0.070 |
Why?
|
Ubiquitin | 2 | 2004 | 78 | 0.070 |
Why?
|
Atherosclerosis | 1 | 2008 | 134 | 0.070 |
Why?
|
Spinal Cord | 4 | 1991 | 94 | 0.070 |
Why?
|
Clusterin | 1 | 2006 | 9 | 0.070 |
Why?
|
Muscle Cells | 1 | 2006 | 11 | 0.070 |
Why?
|
Energy Intake | 1 | 2007 | 170 | 0.070 |
Why?
|
Inflammation Mediators | 2 | 2021 | 123 | 0.070 |
Why?
|
Recombination, Genetic | 1 | 2006 | 93 | 0.070 |
Why?
|
Immunity, Innate | 2 | 2020 | 149 | 0.070 |
Why?
|
Likelihood Functions | 1 | 2005 | 59 | 0.070 |
Why?
|
Glioma | 1 | 2006 | 79 | 0.070 |
Why?
|
Choline O-Acetyltransferase | 2 | 2018 | 34 | 0.070 |
Why?
|
Structure-Activity Relationship | 2 | 2017 | 409 | 0.070 |
Why?
|
Carnosine | 1 | 2005 | 1 | 0.070 |
Why?
|
Antigen-Antibody Complex | 4 | 2009 | 19 | 0.070 |
Why?
|
Financial Support | 1 | 2005 | 7 | 0.070 |
Why?
|
Adenosine Triphosphate | 3 | 2011 | 196 | 0.070 |
Why?
|
Transforming Growth Factor beta1 | 1 | 2006 | 93 | 0.070 |
Why?
|
Cell Physiological Phenomena | 1 | 2005 | 9 | 0.060 |
Why?
|
Arachidonic Acid | 4 | 2003 | 35 | 0.060 |
Why?
|
Biology | 1 | 2005 | 16 | 0.060 |
Why?
|
Biotechnology | 1 | 2005 | 15 | 0.060 |
Why?
|
Tandem Mass Spectrometry | 2 | 2018 | 182 | 0.060 |
Why?
|
Phagocytosis | 3 | 2003 | 69 | 0.060 |
Why?
|
Synucleins | 2 | 2004 | 6 | 0.060 |
Why?
|
Cricetinae | 2 | 2013 | 238 | 0.060 |
Why?
|
Cell Count | 3 | 2007 | 135 | 0.060 |
Why?
|
Transforming Growth Factor beta | 1 | 2006 | 197 | 0.060 |
Why?
|
Academies and Institutes | 1 | 2005 | 37 | 0.060 |
Why?
|
Amino Acid Motifs | 1 | 2005 | 91 | 0.060 |
Why?
|
Ribosomal Protein S6 Kinases, 90-kDa | 1 | 2005 | 22 | 0.060 |
Why?
|
Iron Regulatory Protein 2 | 2 | 2010 | 2 | 0.060 |
Why?
|
Quinones | 1 | 2004 | 14 | 0.060 |
Why?
|
Time | 1 | 2004 | 14 | 0.060 |
Why?
|
Biopolymers | 1 | 2004 | 18 | 0.060 |
Why?
|
Iron Regulatory Protein 1 | 2 | 2010 | 5 | 0.060 |
Why?
|
Hyperlipoproteinemia Type II | 1 | 2004 | 4 | 0.060 |
Why?
|
X-Rays | 2 | 2018 | 18 | 0.060 |
Why?
|
PrPSc Proteins | 1 | 2004 | 2 | 0.060 |
Why?
|
Adaptor Proteins, Signal Transducing | 2 | 2003 | 190 | 0.060 |
Why?
|
Scrapie | 1 | 2004 | 14 | 0.060 |
Why?
|
Ice Cover | 1 | 2024 | 2 | 0.060 |
Why?
|
Peroxidases | 1 | 2004 | 15 | 0.060 |
Why?
|
Radioimmunotherapy | 1 | 2024 | 2 | 0.060 |
Why?
|
Encephalomyelitis, Autoimmune, Experimental | 1 | 2005 | 54 | 0.060 |
Why?
|
Transcription, Genetic | 3 | 2011 | 578 | 0.060 |
Why?
|
Models, Animal | 2 | 2002 | 134 | 0.060 |
Why?
|
Cyclin B | 1 | 2004 | 7 | 0.060 |
Why?
|
Acid Phosphatase | 2 | 1995 | 21 | 0.060 |
Why?
|
Phodopus | 1 | 2013 | 3 | 0.060 |
Why?
|
Myogenin | 1 | 2013 | 5 | 0.060 |
Why?
|
MyoD Protein | 1 | 2013 | 9 | 0.060 |
Why?
|
Cyclins | 1 | 2004 | 37 | 0.060 |
Why?
|
Genetic Testing | 2 | 2018 | 75 | 0.060 |
Why?
|
Biopsy | 2 | 2003 | 164 | 0.060 |
Why?
|
p300-CBP Transcription Factors | 1 | 2013 | 10 | 0.060 |
Why?
|
Aluminum | 2 | 2006 | 36 | 0.060 |
Why?
|
Chemical Precipitation | 1 | 2003 | 8 | 0.060 |
Why?
|
Reproduction | 2 | 2020 | 71 | 0.060 |
Why?
|
Fluorescent Antibody Technique, Indirect | 2 | 2018 | 35 | 0.060 |
Why?
|
Dopamine | 1 | 2005 | 245 | 0.060 |
Why?
|
Asthma | 1 | 2008 | 380 | 0.060 |
Why?
|
Enhancer Elements, Genetic | 1 | 2013 | 62 | 0.060 |
Why?
|
Wiskott-Aldrich Syndrome | 1 | 2003 | 4 | 0.060 |
Why?
|
Introns | 1 | 2013 | 75 | 0.060 |
Why?
|
Drug Antagonism | 1 | 2003 | 5 | 0.060 |
Why?
|
Glutathione Peroxidase | 2 | 2001 | 111 | 0.060 |
Why?
|
Practice Guidelines as Topic | 1 | 2004 | 191 | 0.060 |
Why?
|
Pneumonia, Bacterial | 1 | 2013 | 22 | 0.060 |
Why?
|
Aorta | 2 | 2004 | 167 | 0.060 |
Why?
|
Biological Transport, Active | 3 | 2016 | 26 | 0.060 |
Why?
|
PPAR gamma | 1 | 2013 | 53 | 0.060 |
Why?
|
Severity of Illness Index | 2 | 2020 | 610 | 0.060 |
Why?
|
Estrogen Receptor Modulators | 1 | 2003 | 19 | 0.060 |
Why?
|
NAD(P)H Dehydrogenase (Quinone) | 1 | 2003 | 16 | 0.060 |
Why?
|
Blood Proteins | 2 | 2017 | 66 | 0.060 |
Why?
|
Consensus | 1 | 2023 | 45 | 0.060 |
Why?
|
BRCA2 Protein | 1 | 2023 | 37 | 0.060 |
Why?
|
Microfilament Proteins | 1 | 2003 | 69 | 0.060 |
Why?
|
Random Allocation | 3 | 2008 | 139 | 0.060 |
Why?
|
Gene Knockdown Techniques | 1 | 2013 | 173 | 0.060 |
Why?
|
PTEN Phosphohydrolase | 1 | 2023 | 54 | 0.060 |
Why?
|
Phosphatidylinositols | 2 | 1993 | 12 | 0.060 |
Why?
|
Physiology, Comparative | 1 | 2002 | 1 | 0.060 |
Why?
|
Causality | 2 | 2019 | 44 | 0.060 |
Why?
|
Chlamydia trachomatis | 1 | 2013 | 68 | 0.060 |
Why?
|
Muscular Diseases | 1 | 2003 | 20 | 0.060 |
Why?
|
Acrolein | 1 | 2003 | 16 | 0.060 |
Why?
|
Mendelian Randomization Analysis | 1 | 2023 | 12 | 0.060 |
Why?
|
Animal Feed | 1 | 2003 | 43 | 0.050 |
Why?
|
Threonine | 2 | 2018 | 25 | 0.050 |
Why?
|
Electron Transport Chain Complex Proteins | 2 | 2015 | 12 | 0.050 |
Why?
|
Deoxyribonucleases | 1 | 2002 | 25 | 0.050 |
Why?
|
Tamoxifen | 1 | 2003 | 65 | 0.050 |
Why?
|
Body Temperature | 1 | 2002 | 36 | 0.050 |
Why?
|
HMGB1 Protein | 1 | 2003 | 29 | 0.050 |
Why?
|
Chlamydia muridarum | 1 | 2013 | 104 | 0.050 |
Why?
|
Protein Folding | 1 | 2003 | 127 | 0.050 |
Why?
|
Presynaptic Terminals | 1 | 2023 | 53 | 0.050 |
Why?
|
Respiratory Burst | 1 | 2002 | 4 | 0.050 |
Why?
|
Receptors, Glutamate | 1 | 2002 | 27 | 0.050 |
Why?
|
Iodine Radioisotopes | 1 | 2002 | 35 | 0.050 |
Why?
|
Anticoagulants | 1 | 2003 | 102 | 0.050 |
Why?
|
Succinates | 1 | 2022 | 3 | 0.050 |
Why?
|
Intracranial Hemorrhages | 1 | 2002 | 26 | 0.050 |
Why?
|
Lipid Metabolism | 2 | 2017 | 119 | 0.050 |
Why?
|
Lactates | 1 | 2022 | 8 | 0.050 |
Why?
|
Disulfides | 2 | 2000 | 77 | 0.050 |
Why?
|
Glutamates | 1 | 2022 | 22 | 0.050 |
Why?
|
Feedback | 4 | 2007 | 53 | 0.050 |
Why?
|
Interferon-gamma | 1 | 2013 | 250 | 0.050 |
Why?
|
Molecular Chaperones | 1 | 2002 | 61 | 0.050 |
Why?
|
Inositol | 1 | 2022 | 21 | 0.050 |
Why?
|
Metals, Heavy | 1 | 2003 | 60 | 0.050 |
Why?
|
Heparan Sulfate Proteoglycans | 2 | 1992 | 12 | 0.050 |
Why?
|
Multiple System Atrophy | 1 | 2002 | 2 | 0.050 |
Why?
|
Electrophoresis, Polyacrylamide Gel | 5 | 2001 | 201 | 0.050 |
Why?
|
United States Food and Drug Administration | 1 | 2022 | 22 | 0.050 |
Why?
|
Drug Approval | 1 | 2022 | 8 | 0.050 |
Why?
|
Cytochalasin B | 2 | 1988 | 4 | 0.050 |
Why?
|
Ganglia, Spinal | 2 | 1993 | 37 | 0.050 |
Why?
|
Cadaver | 1 | 2002 | 42 | 0.050 |
Why?
|
Indium | 1 | 2021 | 1 | 0.050 |
Why?
|
Apoptosis Regulatory Proteins | 2 | 2004 | 147 | 0.050 |
Why?
|
Mutation, Missense | 2 | 2012 | 83 | 0.050 |
Why?
|
N-Methylaspartate | 1 | 2002 | 57 | 0.050 |
Why?
|
Propensity Score | 1 | 2021 | 38 | 0.050 |
Why?
|
NADPH-Ferrihemoprotein Reductase | 1 | 2001 | 9 | 0.050 |
Why?
|
Protein Transport | 3 | 2009 | 302 | 0.050 |
Why?
|
CD4-Positive T-Lymphocytes | 1 | 2013 | 259 | 0.050 |
Why?
|
Aorta, Thoracic | 1 | 2001 | 28 | 0.050 |
Why?
|
Computer Simulation | 2 | 2016 | 362 | 0.050 |
Why?
|
Tunica Intima | 1 | 2001 | 19 | 0.050 |
Why?
|
Sodium Dodecyl Sulfate | 2 | 2004 | 21 | 0.050 |
Why?
|
Serotonin | 1 | 2002 | 123 | 0.050 |
Why?
|
Goiter, Nodular | 1 | 2001 | 2 | 0.050 |
Why?
|
Hyperlipidemias | 1 | 2001 | 36 | 0.050 |
Why?
|
Models, Molecular | 3 | 2016 | 808 | 0.050 |
Why?
|
Zygote | 1 | 1981 | 39 | 0.050 |
Why?
|
Interleukin-1 | 1 | 2001 | 35 | 0.050 |
Why?
|
Tumor Suppressor Proteins | 1 | 2003 | 194 | 0.050 |
Why?
|
2,4-Dichlorophenoxyacetic Acid | 1 | 2001 | 1 | 0.050 |
Why?
|
Diabetes Mellitus, Type 1 | 1 | 2001 | 68 | 0.050 |
Why?
|
Hypothyroidism | 1 | 2001 | 18 | 0.050 |
Why?
|
Purkinje Cells | 1 | 2001 | 20 | 0.050 |
Why?
|
Protein Structure, Tertiary | 2 | 2012 | 408 | 0.050 |
Why?
|
Testis | 2 | 1993 | 187 | 0.050 |
Why?
|
Bradykinin | 1 | 2001 | 22 | 0.050 |
Why?
|
Glutathione Reductase | 1 | 2001 | 23 | 0.050 |
Why?
|
Neuronal Plasticity | 1 | 2022 | 103 | 0.050 |
Why?
|
Chromosomes, Human, Pair 9 | 1 | 2000 | 7 | 0.050 |
Why?
|
Drug Interactions | 2 | 2005 | 141 | 0.050 |
Why?
|
Receptors, LH | 3 | 2007 | 4 | 0.050 |
Why?
|
Prognosis | 2 | 2017 | 739 | 0.050 |
Why?
|
Naphthoquinones | 1 | 1981 | 36 | 0.050 |
Why?
|
Comorbidity | 1 | 2023 | 623 | 0.050 |
Why?
|
Follicle Stimulating Hormone | 2 | 2015 | 43 | 0.050 |
Why?
|
Cholesterol, Dietary | 1 | 2000 | 10 | 0.050 |
Why?
|
Membrane Lipids | 1 | 2001 | 33 | 0.050 |
Why?
|
Muscle, Smooth | 1 | 2001 | 58 | 0.050 |
Why?
|
Intercellular Junctions | 2 | 1990 | 17 | 0.050 |
Why?
|
Bronchi | 1 | 2001 | 46 | 0.050 |
Why?
|
Estrus Synchronization | 1 | 2020 | 1 | 0.050 |
Why?
|
Cell Membrane | 3 | 2000 | 381 | 0.050 |
Why?
|
Faculty | 1 | 2021 | 94 | 0.050 |
Why?
|
Catalase | 1 | 2001 | 109 | 0.050 |
Why?
|
Herbicides | 1 | 2001 | 44 | 0.050 |
Why?
|
Animals, Genetically Modified | 2 | 2002 | 99 | 0.050 |
Why?
|
Deferoxamine | 3 | 2010 | 19 | 0.050 |
Why?
|
Medicine in Literature | 1 | 2020 | 2 | 0.050 |
Why?
|
Tomography, Emission-Computed, Single-Photon | 1 | 2000 | 16 | 0.050 |
Why?
|
RNA, Bacterial | 1 | 2020 | 33 | 0.050 |
Why?
|
Technetium | 1 | 2000 | 11 | 0.050 |
Why?
|
Drosophila Proteins | 1 | 2002 | 171 | 0.050 |
Why?
|
Lysosomes | 2 | 2015 | 91 | 0.050 |
Why?
|
Fertility | 1 | 2020 | 59 | 0.040 |
Why?
|
Mentors | 1 | 2021 | 127 | 0.040 |
Why?
|
Pentose Phosphate Pathway | 1 | 1999 | 2 | 0.040 |
Why?
|
Cell Fractionation | 2 | 1998 | 30 | 0.040 |
Why?
|
Progesterone | 1 | 2020 | 113 | 0.040 |
Why?
|
Freezing | 1 | 1999 | 16 | 0.040 |
Why?
|
Gabon | 1 | 2019 | 1 | 0.040 |
Why?
|
Trust | 1 | 2021 | 133 | 0.040 |
Why?
|
Drug Synergism | 1 | 2020 | 177 | 0.040 |
Why?
|
Forensic Genetics | 1 | 2019 | 2 | 0.040 |
Why?
|
Forensic Anthropology | 1 | 2019 | 2 | 0.040 |
Why?
|
Cameroon | 1 | 2019 | 38 | 0.040 |
Why?
|
Protein Kinases | 2 | 2015 | 100 | 0.040 |
Why?
|
RNA, Ribosomal, 16S | 1 | 2020 | 171 | 0.040 |
Why?
|
Program Evaluation | 1 | 2021 | 339 | 0.040 |
Why?
|
Hydrogen-Ion Concentration | 4 | 1985 | 364 | 0.040 |
Why?
|
Aspartic Acid | 2 | 2013 | 47 | 0.040 |
Why?
|
Regulatory Sequences, Nucleic Acid | 1 | 2019 | 49 | 0.040 |
Why?
|
Food Deprivation | 1 | 1999 | 30 | 0.040 |
Why?
|
Quinone Reductases | 1 | 1999 | 1 | 0.040 |
Why?
|
Liver Neoplasms | 1 | 2002 | 190 | 0.040 |
Why?
|
Vitamin E | 3 | 2006 | 61 | 0.040 |
Why?
|
Gene Knock-In Techniques | 1 | 2019 | 14 | 0.040 |
Why?
|
Acylation | 1 | 2018 | 10 | 0.040 |
Why?
|
Tomography, X-Ray Computed | 1 | 2020 | 214 | 0.040 |
Why?
|
Cysteine | 3 | 2005 | 98 | 0.040 |
Why?
|
Creatine Kinase, BB Form | 1 | 2018 | 1 | 0.040 |
Why?
|
Gestational Age | 3 | 1998 | 190 | 0.040 |
Why?
|
Coculture Techniques | 2 | 2015 | 101 | 0.040 |
Why?
|
Microsomes | 1 | 1998 | 52 | 0.040 |
Why?
|
Synchrotrons | 1 | 2018 | 6 | 0.040 |
Why?
|
Sodium-Potassium-Exchanging ATPase | 1 | 1998 | 28 | 0.040 |
Why?
|
Phosphopyruvate Hydratase | 1 | 2018 | 33 | 0.040 |
Why?
|
Metabolic Networks and Pathways | 1 | 2019 | 67 | 0.040 |
Why?
|
Genetic Markers | 2 | 2010 | 142 | 0.040 |
Why?
|
Precipitin Tests | 2 | 1999 | 52 | 0.040 |
Why?
|
Iron-Regulatory Proteins | 1 | 1998 | 2 | 0.040 |
Why?
|
Polypharmacy | 1 | 2018 | 25 | 0.040 |
Why?
|
Papio hamadryas | 1 | 2018 | 3 | 0.040 |
Why?
|
Spermatozoa | 1 | 1980 | 200 | 0.040 |
Why?
|
Adenosine Triphosphatases | 1 | 1998 | 82 | 0.040 |
Why?
|
Prosencephalon | 1 | 2018 | 25 | 0.040 |
Why?
|
Receptors, Somatotropin | 1 | 2018 | 12 | 0.040 |
Why?
|
Salts | 1 | 2018 | 16 | 0.040 |
Why?
|
Rosmarinus | 1 | 2017 | 1 | 0.040 |
Why?
|
Gait Disorders, Neurologic | 1 | 2018 | 11 | 0.040 |
Why?
|
Tremor | 1 | 2018 | 9 | 0.040 |
Why?
|
Quinazolinones | 1 | 2017 | 6 | 0.040 |
Why?
|
Vibration | 1 | 2017 | 23 | 0.040 |
Why?
|
Doxycycline | 1 | 2018 | 30 | 0.040 |
Why?
|
Magnetic Resonance Spectroscopy | 2 | 2010 | 289 | 0.040 |
Why?
|
Trans-Activators | 2 | 2011 | 174 | 0.040 |
Why?
|
Recovery of Function | 1 | 2018 | 88 | 0.040 |
Why?
|
Health Services Needs and Demand | 1 | 2019 | 146 | 0.040 |
Why?
|
Prostaglandins E | 1 | 1997 | 3 | 0.040 |
Why?
|
Tocopherols | 1 | 2017 | 65 | 0.040 |
Why?
|
Extracellular Matrix | 1 | 1998 | 115 | 0.040 |
Why?
|
Doxorubicin | 1 | 2017 | 84 | 0.040 |
Why?
|
Leucine | 1 | 2017 | 29 | 0.040 |
Why?
|
Repressor Proteins | 1 | 2019 | 249 | 0.040 |
Why?
|
Lectins | 2 | 1998 | 20 | 0.040 |
Why?
|
Proline | 1 | 2017 | 43 | 0.040 |
Why?
|
Lipoproteins, LDL | 1 | 1997 | 62 | 0.040 |
Why?
|
Proto-Oncogene Proteins | 3 | 2005 | 239 | 0.040 |
Why?
|
Parasitic Sensitivity Tests | 1 | 2016 | 14 | 0.040 |
Why?
|
Nitric Oxide Synthase Type I | 3 | 2001 | 56 | 0.040 |
Why?
|
Lipoxygenase | 3 | 1985 | 5 | 0.040 |
Why?
|
Public Health | 1 | 2021 | 372 | 0.040 |
Why?
|
Multiprotein Complexes | 2 | 2007 | 54 | 0.030 |
Why?
|
Alkalies | 1 | 1996 | 5 | 0.030 |
Why?
|
Formates | 1 | 1996 | 5 | 0.030 |
Why?
|
Hemostatics | 1 | 1996 | 8 | 0.030 |
Why?
|
Guanidine | 1 | 1996 | 13 | 0.030 |
Why?
|
Microscopy | 2 | 2009 | 32 | 0.030 |
Why?
|
Protein Denaturation | 1 | 1996 | 43 | 0.030 |
Why?
|
Guanidines | 1 | 1996 | 17 | 0.030 |
Why?
|
Colorectal Neoplasms | 1 | 2002 | 441 | 0.030 |
Why?
|
Induced Pluripotent Stem Cells | 1 | 2016 | 37 | 0.030 |
Why?
|
Alternative Splicing | 1 | 2016 | 85 | 0.030 |
Why?
|
National Institutes of Health (U.S.) | 1 | 2016 | 88 | 0.030 |
Why?
|
Gene Frequency | 2 | 2012 | 195 | 0.030 |
Why?
|
Urea | 1 | 1996 | 41 | 0.030 |
Why?
|
Interleukin-10 | 1 | 2016 | 75 | 0.030 |
Why?
|
Glutamic Acid | 2 | 2010 | 128 | 0.030 |
Why?
|
Algorithms | 2 | 2011 | 465 | 0.030 |
Why?
|
Serum Amyloid A Protein | 1 | 1995 | 14 | 0.030 |
Why?
|
Life Expectancy | 1 | 1996 | 42 | 0.030 |
Why?
|
Oligopeptides | 2 | 2013 | 102 | 0.030 |
Why?
|
Hydroxymethylglutaryl-CoA Reductase Inhibitors | 2 | 2008 | 77 | 0.030 |
Why?
|
Hormone Antagonists | 2 | 2006 | 14 | 0.030 |
Why?
|
Crystallography, X-Ray | 1 | 2016 | 265 | 0.030 |
Why?
|
Vegetables | 1 | 2017 | 147 | 0.030 |
Why?
|
Fetus | 2 | 1993 | 105 | 0.030 |
Why?
|
Point Mutation | 2 | 2006 | 93 | 0.030 |
Why?
|
Calmodulin | 2 | 1987 | 46 | 0.030 |
Why?
|
Cell Proliferation | 2 | 2012 | 1198 | 0.030 |
Why?
|
Specific Pathogen-Free Organisms | 1 | 2015 | 20 | 0.030 |
Why?
|
Caspase 1 | 1 | 2015 | 15 | 0.030 |
Why?
|
Diabetes Complications | 1 | 1996 | 90 | 0.030 |
Why?
|
Fruit | 1 | 2017 | 173 | 0.030 |
Why?
|
In Situ Nick-End Labeling | 2 | 2007 | 133 | 0.030 |
Why?
|
Hypothalamus | 2 | 2006 | 129 | 0.030 |
Why?
|
Mice, Obese | 1 | 2015 | 40 | 0.030 |
Why?
|
Biotin | 2 | 2009 | 24 | 0.030 |
Why?
|
Cytosol | 3 | 2004 | 93 | 0.030 |
Why?
|
Mental Disorders | 1 | 2019 | 309 | 0.030 |
Why?
|
Interleukin-1beta | 1 | 2015 | 70 | 0.030 |
Why?
|
Delayed-Action Preparations | 1 | 2015 | 60 | 0.030 |
Why?
|
Longitudinal Studies | 1 | 2018 | 885 | 0.030 |
Why?
|
Chickens | 2 | 1986 | 133 | 0.030 |
Why?
|
Receptors, Cell Surface | 3 | 2002 | 144 | 0.030 |
Why?
|
Anti-Bacterial Agents | 1 | 2018 | 352 | 0.030 |
Why?
|
RNA, Small Interfering | 1 | 2017 | 409 | 0.030 |
Why?
|
Double-Blind Method | 1 | 2015 | 286 | 0.030 |
Why?
|
Amino Acid Chloromethyl Ketones | 1 | 2013 | 8 | 0.030 |
Why?
|
Protozoan Proteins | 1 | 2016 | 182 | 0.030 |
Why?
|
Blood-Testis Barrier | 1 | 1993 | 3 | 0.030 |
Why?
|
Interleukin-7 | 1 | 1993 | 7 | 0.030 |
Why?
|
Desmin | 1 | 1993 | 2 | 0.030 |
Why?
|
Complement System Proteins | 1 | 1993 | 21 | 0.030 |
Why?
|
Actinin | 1 | 1993 | 8 | 0.030 |
Why?
|
Phosphoric Diester Hydrolases | 1 | 1993 | 19 | 0.030 |
Why?
|
Psychiatric Status Rating Scales | 1 | 2015 | 253 | 0.030 |
Why?
|
Urban Population | 1 | 2016 | 333 | 0.030 |
Why?
|
Ferrous Compounds | 2 | 2006 | 20 | 0.030 |
Why?
|
Postmenopause | 2 | 2005 | 128 | 0.030 |
Why?
|
Glutathione Disulfide | 1 | 2013 | 8 | 0.030 |
Why?
|
Ependyma | 2 | 1991 | 5 | 0.030 |
Why?
|
Cyanides | 2 | 1985 | 11 | 0.030 |
Why?
|
Adenine Nucleotides | 1 | 2013 | 6 | 0.030 |
Why?
|
Bone Marrow Cells | 1 | 1993 | 81 | 0.030 |
Why?
|
Escape Reaction | 1 | 2013 | 15 | 0.030 |
Why?
|
Neurons, Afferent | 1 | 1993 | 43 | 0.030 |
Why?
|
Muscular Dystrophies | 1 | 1993 | 2 | 0.030 |
Why?
|
Cell Nucleus Division | 1 | 2013 | 1 | 0.030 |
Why?
|
Cyclin-Dependent Kinase 5 | 2 | 2004 | 8 | 0.030 |
Why?
|
Myositis | 1 | 1993 | 7 | 0.030 |
Why?
|
Cross-Sectional Studies | 1 | 2021 | 2721 | 0.030 |
Why?
|
Thymus Gland | 1 | 1993 | 81 | 0.030 |
Why?
|
Chromosomal Instability | 1 | 2013 | 22 | 0.030 |
Why?
|
Interpersonal Relations | 1 | 2015 | 205 | 0.030 |
Why?
|
Lactic Acid | 1 | 2013 | 95 | 0.030 |
Why?
|
Incidence | 1 | 1996 | 922 | 0.030 |
Why?
|
Presenilin-2 | 2 | 2004 | 2 | 0.030 |
Why?
|
Receptor, IGF Type 1 | 1 | 2012 | 26 | 0.030 |
Why?
|
Radioimmunoassay | 2 | 2004 | 65 | 0.030 |
Why?
|
Databases, Factual | 1 | 2014 | 291 | 0.030 |
Why?
|
Reaction Time | 1 | 2013 | 143 | 0.030 |
Why?
|
Lymphocyte Activation | 1 | 1993 | 236 | 0.030 |
Why?
|
Tetrazolium Salts | 1 | 2012 | 36 | 0.030 |
Why?
|
Pentetic Acid | 2 | 2004 | 4 | 0.030 |
Why?
|
Epithelium | 2 | 1990 | 79 | 0.030 |
Why?
|
Proto-Oncogene Proteins c-akt | 2 | 2005 | 269 | 0.030 |
Why?
|
Health Status Disparities | 1 | 2019 | 642 | 0.030 |
Why?
|
MAP Kinase Kinase 6 | 2 | 2002 | 2 | 0.030 |
Why?
|
Multienzyme Complexes | 2 | 2004 | 69 | 0.030 |
Why?
|
Glycolipids | 1 | 1992 | 9 | 0.030 |
Why?
|
Neoplasm Metastasis | 1 | 1993 | 219 | 0.030 |
Why?
|
Insulin-Like Growth Factor I | 1 | 2012 | 70 | 0.030 |
Why?
|
Adaptive Immunity | 1 | 2012 | 27 | 0.030 |
Why?
|
Methanol | 1 | 1992 | 18 | 0.030 |
Why?
|
Nuclear Respiratory Factors | 1 | 2011 | 1 | 0.030 |
Why?
|
Mitogen-Activated Protein Kinase 8 | 2 | 2003 | 12 | 0.030 |
Why?
|
Thiazoles | 1 | 2012 | 74 | 0.030 |
Why?
|
CREB-Binding Protein | 1 | 2011 | 13 | 0.030 |
Why?
|
Malaria, Cerebral | 1 | 1992 | 31 | 0.030 |
Why?
|
Chemotaxis | 1 | 2012 | 60 | 0.030 |
Why?
|
Tissue Culture Techniques | 1 | 2011 | 32 | 0.030 |
Why?
|
Mutant Proteins | 1 | 2012 | 51 | 0.030 |
Why?
|
Proteasome Endopeptidase Complex | 2 | 2004 | 114 | 0.030 |
Why?
|
Okadaic Acid | 2 | 2002 | 15 | 0.030 |
Why?
|
Neutrophils | 2 | 2000 | 131 | 0.030 |
Why?
|
Fluoresceins | 2 | 2007 | 27 | 0.020 |
Why?
|
Adenosine Diphosphate | 1 | 2011 | 21 | 0.020 |
Why?
|
Dendritic Cells | 1 | 2012 | 113 | 0.020 |
Why?
|
Meninges | 1 | 1991 | 6 | 0.020 |
Why?
|
Nasal Mucosa | 1 | 1991 | 29 | 0.020 |
Why?
|
Tyrosine 3-Monooxygenase | 1 | 2011 | 78 | 0.020 |
Why?
|
Silver | 1 | 1991 | 54 | 0.020 |
Why?
|
Injections, Intraventricular | 1 | 2011 | 64 | 0.020 |
Why?
|
Gene Regulatory Networks | 1 | 2012 | 120 | 0.020 |
Why?
|
Genetic Vectors | 1 | 2011 | 158 | 0.020 |
Why?
|
Nitric Oxide Synthase Type III | 2 | 2001 | 67 | 0.020 |
Why?
|
Guanosine Diphosphate | 1 | 2010 | 12 | 0.020 |
Why?
|
Mitogen-Activated Protein Kinase 9 | 2 | 2001 | 3 | 0.020 |
Why?
|
Brain Ischemia | 1 | 1993 | 184 | 0.020 |
Why?
|
Luminol | 1 | 2010 | 1 | 0.020 |
Why?
|
Guanosine Triphosphate | 1 | 2010 | 18 | 0.020 |
Why?
|
Insulin Resistance | 1 | 2012 | 184 | 0.020 |
Why?
|
Amnesia | 1 | 2010 | 8 | 0.020 |
Why?
|
Luminescent Measurements | 1 | 2010 | 26 | 0.020 |
Why?
|
Stress, Physiological | 1 | 2012 | 150 | 0.020 |
Why?
|
Gene Silencing | 1 | 2011 | 151 | 0.020 |
Why?
|
Bile Canaliculi | 1 | 1990 | 1 | 0.020 |
Why?
|
Ethylnitrosourea | 1 | 1990 | 2 | 0.020 |
Why?
|
Bile Ducts, Intrahepatic | 1 | 1990 | 4 | 0.020 |
Why?
|
Fluorescent Dyes | 1 | 2011 | 181 | 0.020 |
Why?
|
Formaldehyde | 1 | 2010 | 33 | 0.020 |
Why?
|
Citric Acid Cycle | 1 | 2010 | 6 | 0.020 |
Why?
|
Receptors, AMPA | 1 | 2010 | 56 | 0.020 |
Why?
|
Probability | 1 | 2010 | 78 | 0.020 |
Why?
|
Peroxidase | 1 | 2010 | 49 | 0.020 |
Why?
|
Rodentia | 1 | 2010 | 43 | 0.020 |
Why?
|
Subacute Sclerosing Panencephalitis | 1 | 1989 | 1 | 0.020 |
Why?
|
Microinjections | 2 | 2003 | 57 | 0.020 |
Why?
|
Spain | 1 | 2010 | 36 | 0.020 |
Why?
|
Benzoates | 1 | 2010 | 16 | 0.020 |
Why?
|
Protective Agents | 1 | 2010 | 25 | 0.020 |
Why?
|
Electron Transport | 1 | 2010 | 40 | 0.020 |
Why?
|
Hypoxia-Inducible Factor 1 | 1 | 2010 | 11 | 0.020 |
Why?
|
Buthionine Sulfoximine | 1 | 2009 | 12 | 0.020 |
Why?
|
Antiparkinson Agents | 1 | 2009 | 12 | 0.020 |
Why?
|
Protein Phosphatase 2 | 1 | 2009 | 22 | 0.020 |
Why?
|
Calcium Signaling | 1 | 2011 | 101 | 0.020 |
Why?
|
Amygdala | 1 | 1990 | 114 | 0.020 |
Why?
|
Congresses as Topic | 1 | 2010 | 42 | 0.020 |
Why?
|
Luminescent Proteins | 1 | 2010 | 77 | 0.020 |
Why?
|
Age of Onset | 1 | 2010 | 100 | 0.020 |
Why?
|
Receptors, G-Protein-Coupled | 1 | 2010 | 86 | 0.020 |
Why?
|
Dimerization | 1 | 2009 | 112 | 0.020 |
Why?
|
Concept Formation | 1 | 2009 | 20 | 0.020 |
Why?
|
Proto-Oncogene Proteins c-bcl-2 | 2 | 2003 | 152 | 0.020 |
Why?
|
Seroepidemiologic Studies | 1 | 2009 | 68 | 0.020 |
Why?
|
Cyclooxygenase 1 | 1 | 2009 | 11 | 0.020 |
Why?
|
Hydroxymethylbilane Synthase | 1 | 2009 | 1 | 0.020 |
Why?
|
Porphobilinogen Synthase | 1 | 2009 | 4 | 0.020 |
Why?
|
Thiobarbituric Acid Reactive Substances | 2 | 2000 | 15 | 0.020 |
Why?
|
Ferritins | 1 | 2010 | 55 | 0.020 |
Why?
|
Uncoupling Agents | 1 | 2009 | 3 | 0.020 |
Why?
|
Boronic Acids | 1 | 2009 | 19 | 0.020 |
Why?
|
Collagen Type XI | 1 | 2009 | 2 | 0.020 |
Why?
|
Mitochondrial Membrane Transport Proteins | 1 | 2009 | 33 | 0.020 |
Why?
|
Acetylation | 1 | 2009 | 98 | 0.020 |
Why?
|
Triazoles | 1 | 2010 | 86 | 0.020 |
Why?
|
Electron Transport Complex I | 1 | 2009 | 21 | 0.020 |
Why?
|
Protein Subunits | 1 | 2009 | 87 | 0.020 |
Why?
|
L-Lactate Dehydrogenase | 1 | 2009 | 62 | 0.020 |
Why?
|
Neurotoxins | 1 | 2009 | 57 | 0.020 |
Why?
|
Selenium | 2 | 2001 | 148 | 0.020 |
Why?
|
Diagnosis, Differential | 1 | 1989 | 217 | 0.020 |
Why?
|
Catechin | 1 | 2008 | 31 | 0.020 |
Why?
|
Green Fluorescent Proteins | 1 | 2009 | 208 | 0.020 |
Why?
|
S100 Proteins | 2 | 2001 | 12 | 0.020 |
Why?
|
Electron Probe Microanalysis | 1 | 2008 | 13 | 0.020 |
Why?
|
Prostatic Neoplasms | 1 | 2018 | 935 | 0.020 |
Why?
|
Macrophage Activation | 1 | 2008 | 56 | 0.020 |
Why?
|
Schistosoma mansoni | 1 | 1988 | 18 | 0.020 |
Why?
|
Brain Diseases, Metabolic, Inborn | 1 | 2008 | 1 | 0.020 |
Why?
|
Gene Duplication | 1 | 2008 | 24 | 0.020 |
Why?
|
Phagosomes | 1 | 2007 | 30 | 0.020 |
Why?
|
Quantitative Trait Loci | 1 | 2008 | 77 | 0.020 |
Why?
|
Cell Line, Transformed | 1 | 2007 | 91 | 0.020 |
Why?
|
Phosphatidylcholines | 1 | 2007 | 47 | 0.020 |
Why?
|
Follow-Up Studies | 1 | 2010 | 974 | 0.020 |
Why?
|
Sp Transcription Factors | 1 | 2007 | 1 | 0.020 |
Why?
|
Synteny | 1 | 2007 | 15 | 0.020 |
Why?
|
Extraembryonic Membranes | 1 | 2007 | 6 | 0.020 |
Why?
|
Luteinizing Hormone, beta Subunit | 1 | 2007 | 1 | 0.020 |
Why?
|
Models, Theoretical | 1 | 2009 | 217 | 0.020 |
Why?
|
Achilles Tendon | 1 | 2007 | 2 | 0.020 |
Why?
|
Transgenes | 2 | 1998 | 59 | 0.020 |
Why?
|
Syndrome | 1 | 2007 | 74 | 0.020 |
Why?
|
Abnormalities, Multiple | 1 | 2007 | 36 | 0.020 |
Why?
|
Intraocular Pressure | 1 | 2007 | 112 | 0.020 |
Why?
|
Euchromatin | 1 | 2006 | 6 | 0.020 |
Why?
|
False Negative Reactions | 1 | 2006 | 9 | 0.020 |
Why?
|
Fatal Outcome | 1 | 2007 | 40 | 0.020 |
Why?
|
Smad Proteins | 1 | 2006 | 12 | 0.020 |
Why?
|
False Positive Reactions | 1 | 2006 | 26 | 0.020 |
Why?
|
Molecular Diagnostic Techniques | 1 | 2006 | 14 | 0.020 |
Why?
|
Membrane Glycoproteins | 2 | 2002 | 211 | 0.020 |
Why?
|
Gonads | 1 | 2006 | 20 | 0.020 |
Why?
|
Saccharomyces cerevisiae Proteins | 1 | 2007 | 118 | 0.020 |
Why?
|
CpG Islands | 1 | 2007 | 97 | 0.020 |
Why?
|
Phospholipids | 1 | 2007 | 70 | 0.020 |
Why?
|
Organoids | 1 | 1987 | 22 | 0.020 |
Why?
|
Linkage Disequilibrium | 1 | 2006 | 85 | 0.020 |
Why?
|
Cell Division | 2 | 2000 | 307 | 0.020 |
Why?
|
Autistic Disorder | 1 | 2007 | 37 | 0.020 |
Why?
|
Tumor Suppressor Protein p53 | 1 | 2009 | 213 | 0.020 |
Why?
|
Apolipoprotein A-I | 1 | 2006 | 21 | 0.020 |
Why?
|
Electrophoresis, Gel, Two-Dimensional | 1 | 2006 | 78 | 0.020 |
Why?
|
Necrosis | 1 | 2006 | 49 | 0.020 |
Why?
|
Software | 1 | 2008 | 217 | 0.020 |
Why?
|
Mutagenesis | 2 | 1999 | 89 | 0.020 |
Why?
|
Hypercholesterolemia | 1 | 2006 | 38 | 0.020 |
Why?
|
Intracellular Membranes | 1 | 2006 | 38 | 0.020 |
Why?
|
Monophenol Monooxygenase | 1 | 2006 | 14 | 0.020 |
Why?
|
Drinking | 1 | 2006 | 38 | 0.020 |
Why?
|
Drug Therapy | 1 | 2006 | 17 | 0.020 |
Why?
|
Comet Assay | 1 | 2006 | 76 | 0.020 |
Why?
|
Brain Edema | 1 | 2006 | 63 | 0.020 |
Why?
|
Benzenesulfonates | 1 | 2005 | 8 | 0.020 |
Why?
|
Hydroquinones | 1 | 2005 | 8 | 0.020 |
Why?
|
Butylamines | 1 | 2005 | 2 | 0.020 |
Why?
|
Schiff Bases | 1 | 2005 | 5 | 0.020 |
Why?
|
Gold | 1 | 1987 | 136 | 0.020 |
Why?
|
Chile | 1 | 2005 | 6 | 0.020 |
Why?
|
Indicators and Reagents | 1 | 2005 | 58 | 0.020 |
Why?
|
Membrane Potentials | 1 | 2006 | 223 | 0.020 |
Why?
|
Benzoquinones | 1 | 2005 | 36 | 0.020 |
Why?
|
Spectrophotometry, Ultraviolet | 1 | 2005 | 98 | 0.020 |
Why?
|
Risk Reduction Behavior | 1 | 2006 | 127 | 0.020 |
Why?
|
Financing, Government | 1 | 2005 | 19 | 0.020 |
Why?
|
Alkylation | 1 | 2005 | 11 | 0.020 |
Why?
|
Isotretinoin | 1 | 2005 | 4 | 0.020 |
Why?
|
Hydroxyeicosatetraenoic Acids | 1 | 1985 | 9 | 0.020 |
Why?
|
Enzyme Activators | 1 | 2005 | 12 | 0.020 |
Why?
|
Phospholipases A | 1 | 1985 | 10 | 0.020 |
Why?
|
Netherlands | 1 | 2004 | 10 | 0.020 |
Why?
|
Frozen Sections | 2 | 1999 | 7 | 0.020 |
Why?
|
3T3 Cells | 1 | 2004 | 59 | 0.020 |
Why?
|
Atrophy | 1 | 2005 | 42 | 0.020 |
Why?
|
Gene Expression Regulation, Developmental | 1 | 2007 | 286 | 0.020 |
Why?
|
Arousal | 1 | 2005 | 86 | 0.020 |
Why?
|
Fatty Acids, Unsaturated | 1 | 1985 | 34 | 0.020 |
Why?
|
STAT1 Transcription Factor | 1 | 2005 | 35 | 0.020 |
Why?
|
Serine | 1 | 2005 | 75 | 0.020 |
Why?
|
Premenopause | 1 | 2005 | 104 | 0.020 |
Why?
|
Carbon Monoxide | 1 | 2004 | 34 | 0.020 |
Why?
|
Ovary | 1 | 2005 | 108 | 0.020 |
Why?
|
Nitric Oxide Donors | 1 | 2004 | 18 | 0.020 |
Why?
|
Cystathionine beta-Synthase | 1 | 2004 | 12 | 0.020 |
Why?
|
Chemotaxis, Leukocyte | 1 | 1984 | 22 | 0.020 |
Why?
|
Chymotrypsin | 1 | 2004 | 15 | 0.020 |
Why?
|
Women's Health | 1 | 2005 | 145 | 0.020 |
Why?
|
Matched-Pair Analysis | 1 | 2004 | 9 | 0.020 |
Why?
|
Cyclin B1 | 1 | 2004 | 16 | 0.010 |
Why?
|
G2 Phase | 1 | 2004 | 29 | 0.010 |
Why?
|
Serine Endopeptidases | 1 | 2004 | 38 | 0.010 |
Why?
|
Cyclin-Dependent Kinase Inhibitor p21 | 1 | 2004 | 55 | 0.010 |
Why?
|
Hemoglobins | 1 | 2004 | 107 | 0.010 |
Why?
|
Proteomics | 1 | 2006 | 325 | 0.010 |
Why?
|
Forecasting | 1 | 2004 | 128 | 0.010 |
Why?
|
Wiskott-Aldrich Syndrome Protein Family | 1 | 2003 | 2 | 0.010 |
Why?
|
Wiskott-Aldrich Syndrome Protein, Neuronal | 1 | 2003 | 4 | 0.010 |
Why?
|
Myocardium | 1 | 1986 | 235 | 0.010 |
Why?
|
Memory | 1 | 2005 | 170 | 0.010 |
Why?
|
Antibody Formation | 1 | 1983 | 74 | 0.010 |
Why?
|
MAP Kinase Kinase 1 | 1 | 2003 | 14 | 0.010 |
Why?
|
Staurosporine | 1 | 2003 | 38 | 0.010 |
Why?
|
DNA Methylation | 1 | 2007 | 325 | 0.010 |
Why?
|
Xeroderma Pigmentosum Group A Protein | 1 | 2003 | 3 | 0.010 |
Why?
|
Depression, Chemical | 1 | 2003 | 4 | 0.010 |
Why?
|
Phosphothreonine | 1 | 2003 | 5 | 0.010 |
Why?
|
Stimulation, Chemical | 1 | 2003 | 22 | 0.010 |
Why?
|
Second Messenger Systems | 1 | 2003 | 14 | 0.010 |
Why?
|
Active Transport, Cell Nucleus | 1 | 2003 | 59 | 0.010 |
Why?
|
Reproducibility of Results | 1 | 2006 | 935 | 0.010 |
Why?
|
Cyclin-Dependent Kinase Inhibitor p27 | 1 | 2003 | 21 | 0.010 |
Why?
|
Deoxyadenosines | 1 | 2003 | 9 | 0.010 |
Why?
|
Meningitis | 1 | 2003 | 8 | 0.010 |
Why?
|
Lithium | 1 | 2003 | 15 | 0.010 |
Why?
|
Immunization, Passive | 1 | 2003 | 19 | 0.010 |
Why?
|
Cell Compartmentation | 1 | 2003 | 13 | 0.010 |
Why?
|
Spectrometry, Mass, Electrospray Ionization | 1 | 2004 | 132 | 0.010 |
Why?
|
Estrogen Receptor beta | 1 | 2003 | 40 | 0.010 |
Why?
|
Flocculation | 1 | 2002 | 6 | 0.010 |
Why?
|
Cytochromes | 1 | 2002 | 4 | 0.010 |
Why?
|
Coenzymes | 1 | 2002 | 13 | 0.010 |
Why?
|
Guanine Nucleotide Exchange Factors | 1 | 2003 | 29 | 0.010 |
Why?
|
Spectrometry, Fluorescence | 1 | 2004 | 208 | 0.010 |
Why?
|
DNA Probes | 1 | 2002 | 29 | 0.010 |
Why?
|
Receptors, Kainic Acid | 1 | 2002 | 11 | 0.010 |
Why?
|
Metalloproteins | 1 | 2002 | 25 | 0.010 |
Why?
|
Muscle Fibers, Skeletal | 1 | 2003 | 64 | 0.010 |
Why?
|
Cerebral Amyloid Angiopathy, Familial | 1 | 2002 | 3 | 0.010 |
Why?
|
Sympathetic Nervous System | 1 | 2003 | 74 | 0.010 |
Why?
|
Radionuclide Imaging | 1 | 2002 | 28 | 0.010 |
Why?
|
Nervous System | 1 | 2002 | 29 | 0.010 |
Why?
|
5-Methoxytryptamine | 1 | 2002 | 2 | 0.010 |
Why?
|
Administration, Intranasal | 1 | 2002 | 79 | 0.010 |
Why?
|
Nitrogen Oxides | 1 | 2002 | 5 | 0.010 |
Why?
|
Imidazoles | 1 | 2003 | 126 | 0.010 |
Why?
|
Dietary Fats | 1 | 2003 | 119 | 0.010 |
Why?
|
Pyridines | 1 | 2003 | 116 | 0.010 |
Why?
|
Survival Rate | 1 | 2003 | 311 | 0.010 |
Why?
|
Spectrum Analysis, Raman | 1 | 2003 | 88 | 0.010 |
Why?
|
Autoantigens | 1 | 2002 | 81 | 0.010 |
Why?
|
Receptors, Melatonin | 1 | 2002 | 12 | 0.010 |
Why?
|
Cyclic N-Oxides | 1 | 2002 | 18 | 0.010 |
Why?
|
Receptors, Estrogen | 1 | 2003 | 156 | 0.010 |
Why?
|
HSP70 Heat-Shock Proteins | 1 | 2002 | 47 | 0.010 |
Why?
|
Immunochemistry | 2 | 1995 | 9 | 0.010 |
Why?
|
Receptors, Cytoplasmic and Nuclear | 1 | 2002 | 59 | 0.010 |
Why?
|
I-kappa B Proteins | 1 | 2001 | 41 | 0.010 |
Why?
|
Dihydrolipoamide Dehydrogenase | 1 | 2001 | 2 | 0.010 |
Why?
|
HSP90 Heat-Shock Proteins | 1 | 2002 | 47 | 0.010 |
Why?
|
Transcription Factor RelA | 1 | 2001 | 40 | 0.010 |
Why?
|
Toll-Like Receptor 4 | 1 | 2002 | 62 | 0.010 |
Why?
|
Pigments, Biological | 1 | 1981 | 10 | 0.010 |
Why?
|
Testosterone | 1 | 2002 | 193 | 0.010 |
Why?
|
Receptors, N-Methyl-D-Aspartate | 1 | 2002 | 137 | 0.010 |
Why?
|
Serum Albumin, Bovine | 1 | 2001 | 51 | 0.010 |
Why?
|
Enzyme Induction | 1 | 2001 | 53 | 0.010 |
Why?
|
Hepatocytes | 1 | 2002 | 75 | 0.010 |
Why?
|
Mitogen-Activated Protein Kinase 3 | 1 | 2001 | 103 | 0.010 |
Why?
|
Heterozygote | 1 | 2001 | 93 | 0.010 |
Why?
|
Leukocyte Count | 1 | 2001 | 77 | 0.010 |
Why?
|
Thyroxine | 1 | 2001 | 19 | 0.010 |
Why?
|
Muscle Development | 1 | 2001 | 45 | 0.010 |
Why?
|
Culture Media, Conditioned | 1 | 2001 | 46 | 0.010 |
Why?
|
Nitrites | 1 | 2001 | 46 | 0.010 |
Why?
|
Chaperonin 60 | 1 | 2001 | 18 | 0.010 |
Why?
|
Thyrotropin | 1 | 2001 | 17 | 0.010 |
Why?
|
Isoelectric Point | 1 | 2001 | 9 | 0.010 |
Why?
|
Mitogen-Activated Protein Kinase 10 | 1 | 2001 | 2 | 0.010 |
Why?
|
Fura-2 | 1 | 2001 | 12 | 0.010 |
Why?
|
Leukotrienes | 1 | 2001 | 4 | 0.010 |
Why?
|
Muscarinic Agonists | 1 | 2001 | 10 | 0.010 |
Why?
|
Microvilli | 1 | 2001 | 9 | 0.010 |
Why?
|
Triiodothyronine | 1 | 2001 | 32 | 0.010 |
Why?
|
Behavioral Symptoms | 1 | 2001 | 6 | 0.010 |
Why?
|
Muscarinic Antagonists | 1 | 2001 | 12 | 0.010 |
Why?
|
Organ Culture Techniques | 1 | 2001 | 103 | 0.010 |
Why?
|
Propionates | 1 | 2001 | 26 | 0.010 |
Why?
|
COS Cells | 1 | 2000 | 69 | 0.010 |
Why?
|
Ketones | 1 | 2001 | 17 | 0.010 |
Why?
|
Cholic Acid | 1 | 2000 | 2 | 0.010 |
Why?
|
Thiouracil | 1 | 2000 | 3 | 0.010 |
Why?
|
Phosphoric Monoester Hydrolases | 1 | 2000 | 33 | 0.010 |
Why?
|
Macromolecular Substances | 1 | 2001 | 96 | 0.010 |
Why?
|
Acetylcholine | 1 | 2001 | 73 | 0.010 |
Why?
|
Tritium | 2 | 1992 | 51 | 0.010 |
Why?
|
Cell-Free System | 1 | 2000 | 15 | 0.010 |
Why?
|
Conserved Sequence | 1 | 2000 | 119 | 0.010 |
Why?
|
Quinolines | 1 | 2001 | 64 | 0.010 |
Why?
|
Multigene Family | 1 | 2000 | 106 | 0.010 |
Why?
|
Superoxides | 1 | 2000 | 53 | 0.010 |
Why?
|
Cyclic AMP-Dependent Protein Kinases | 1 | 2000 | 73 | 0.010 |
Why?
|
Ions | 1 | 2000 | 61 | 0.010 |
Why?
|
Sequence Homology, Amino Acid | 1 | 2000 | 269 | 0.010 |
Why?
|
3,3'-Diaminobenzidine | 1 | 2000 | 3 | 0.010 |
Why?
|
Ferric Compounds | 1 | 2000 | 51 | 0.010 |
Why?
|
Corpus Striatum | 1 | 2001 | 104 | 0.010 |
Why?
|
Cloning, Molecular | 1 | 2000 | 325 | 0.010 |
Why?
|
Dithiothreitol | 1 | 1999 | 18 | 0.010 |
Why?
|
Protein-Tyrosine Kinases | 1 | 2001 | 132 | 0.010 |
Why?
|
Epithelial Cells | 1 | 2003 | 384 | 0.010 |
Why?
|
Hela Cells | 1 | 2000 | 366 | 0.010 |
Why?
|
Movement | 1 | 1980 | 97 | 0.010 |
Why?
|
Catalysis | 1 | 2000 | 179 | 0.010 |
Why?
|
Rats, Inbred BN | 1 | 1999 | 21 | 0.010 |
Why?
|
Succinimides | 1 | 1999 | 10 | 0.010 |
Why?
|
Phosphoproteins | 1 | 2000 | 163 | 0.010 |
Why?
|
Saccharomyces cerevisiae | 1 | 2000 | 206 | 0.010 |
Why?
|
Plasmids | 1 | 2000 | 246 | 0.010 |
Why?
|
Chromatography, Gel | 1 | 1999 | 50 | 0.010 |
Why?
|
Ca(2+) Mg(2+)-ATPase | 1 | 1998 | 6 | 0.010 |
Why?
|
Anion Transport Proteins | 1 | 1998 | 2 | 0.010 |
Why?
|
Hydrolysis | 1 | 1999 | 99 | 0.010 |
Why?
|
Polyethylene Glycols | 1 | 1999 | 84 | 0.010 |
Why?
|
bcl-Associated Death Protein | 1 | 1998 | 9 | 0.010 |
Why?
|
Caspase 2 | 1 | 1998 | 7 | 0.010 |
Why?
|
bcl-2 Homologous Antagonist-Killer Protein | 1 | 1998 | 4 | 0.010 |
Why?
|
Enzyme Precursors | 1 | 1998 | 14 | 0.010 |
Why?
|
PC12 Cells | 1 | 1998 | 93 | 0.010 |
Why?
|
bcl-X Protein | 1 | 1998 | 27 | 0.010 |
Why?
|
Crystallins | 1 | 1997 | 2 | 0.010 |
Why?
|
bcl-2-Associated X Protein | 1 | 1998 | 77 | 0.010 |
Why?
|
Meningeal Arteries | 1 | 1997 | 1 | 0.010 |
Why?
|
Mollusca | 1 | 1997 | 14 | 0.010 |
Why?
|
Calcium-Calmodulin-Dependent Protein Kinase Type 2 | 1 | 1996 | 17 | 0.010 |
Why?
|
RNA-Directed DNA Polymerase | 1 | 1995 | 18 | 0.010 |
Why?
|
Pons | 1 | 1995 | 9 | 0.010 |
Why?
|
Cytochrome c Group | 1 | 1995 | 16 | 0.010 |
Why?
|
Phospholipase C delta | 1 | 1995 | 1 | 0.010 |
Why?
|
Osmolar Concentration | 1 | 1995 | 58 | 0.010 |
Why?
|
Glutamate-Ammonia Ligase | 1 | 1993 | 10 | 0.010 |
Why?
|
Receptors, Transferrin | 1 | 1993 | 15 | 0.010 |
Why?
|
Phosphatidylinositol Diacylglycerol-Lyase | 1 | 1993 | 5 | 0.010 |
Why?
|
Capillary Permeability | 1 | 1993 | 30 | 0.010 |
Why?
|
Video Recording | 1 | 1993 | 32 | 0.010 |
Why?
|
Oligodeoxyribonucleotides | 1 | 1993 | 52 | 0.010 |
Why?
|
Pharyngeal Diseases | 1 | 1993 | 6 | 0.010 |
Why?
|
CHO Cells | 1 | 1993 | 124 | 0.010 |
Why?
|
Rats, Inbred SHR | 1 | 1993 | 32 | 0.010 |
Why?
|
Eye Diseases | 1 | 1993 | 24 | 0.010 |
Why?
|
Platelet Membrane Glycoproteins | 1 | 1992 | 4 | 0.010 |
Why?
|
Thrombospondins | 1 | 1992 | 3 | 0.010 |
Why?
|
Guanosine Diphosphate Mannose | 1 | 1992 | 2 | 0.010 |
Why?
|
Splenectomy | 1 | 1992 | 8 | 0.010 |
Why?
|
Uridine Diphosphate N-Acetylglucosamine | 1 | 1992 | 5 | 0.010 |
Why?
|
Sulfur Radioisotopes | 1 | 1992 | 7 | 0.010 |
Why?
|
Cell Fusion | 1 | 1992 | 19 | 0.010 |
Why?
|
Clone Cells | 1 | 1992 | 47 | 0.010 |
Why?
|
Leukemia, Myelogenous, Chronic, BCR-ABL Positive | 1 | 1992 | 18 | 0.010 |
Why?
|
Glycosylphosphatidylinositols | 1 | 1992 | 21 | 0.010 |
Why?
|
Genetic Complementation Test | 1 | 1992 | 59 | 0.010 |
Why?
|
Mannose | 1 | 1992 | 25 | 0.010 |
Why?
|
Intercellular Adhesion Molecule-1 | 1 | 1992 | 56 | 0.010 |
Why?
|
Breast Neoplasms | 1 | 2003 | 1502 | 0.010 |
Why?
|
Lymphoma | 1 | 1992 | 38 | 0.010 |
Why?
|
Cell Adhesion Molecules | 1 | 1992 | 75 | 0.010 |
Why?
|
Antigens, CD | 1 | 1992 | 121 | 0.010 |
Why?
|
Cell Adhesion | 1 | 1992 | 212 | 0.010 |
Why?
|
Animals, Suckling | 1 | 1990 | 10 | 0.010 |
Why?
|
Horseradish Peroxidase | 1 | 1990 | 25 | 0.010 |
Why?
|
Nickel | 1 | 1990 | 20 | 0.010 |
Why?
|
Fixatives | 1 | 1989 | 7 | 0.010 |
Why?
|
Protease Inhibitors | 1 | 1989 | 49 | 0.010 |
Why?
|
Mice, Inbred C3H | 1 | 1988 | 84 | 0.010 |
Why?
|
Spectrin | 1 | 1988 | 5 | 0.000 |
Why?
|
Motor Neurons | 1 | 1988 | 83 | 0.000 |
Why?
|
Ankyrins | 1 | 1988 | 6 | 0.000 |
Why?
|
Anion Exchange Protein 1, Erythrocyte | 1 | 1988 | 6 | 0.000 |
Why?
|
Cyclosporins | 1 | 1987 | 2 | 0.000 |
Why?
|
Egtazic Acid | 1 | 1987 | 13 | 0.000 |
Why?
|
Vinculin | 1 | 1987 | 6 | 0.000 |
Why?
|
N-Formylmethionine Leucyl-Phenylalanine | 1 | 1984 | 3 | 0.000 |
Why?
|
Colchicine | 1 | 1984 | 15 | 0.000 |
Why?
|
Fetal Blood | 1 | 1984 | 50 | 0.000 |
Why?
|
Antigen-Antibody Reactions | 1 | 1983 | 20 | 0.000 |
Why?
|
Placenta | 1 | 1984 | 97 | 0.000 |
Why?
|
Guinea Pigs | 1 | 1983 | 145 | 0.000 |
Why?
|
Hybridomas | 1 | 1983 | 29 | 0.000 |
Why?
|
Immunization | 1 | 1983 | 92 | 0.000 |
Why?
|
Starfish | 1 | 1982 | 2 | 0.000 |
Why?
|
Fishes | 1 | 1982 | 53 | 0.000 |
Why?
|